Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zfx
|
ENSMUSG00000079509.4 | zinc finger protein X-linked |
Zfp711
|
ENSMUSG00000025529.8 | zinc finger protein 711 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_112600583_112600734 | Zfp711 | 132 | 0.969262 | -0.34 | 8.4e-03 | Click! |
chrX_112600792_112602051 | Zfp711 | 895 | 0.641699 | -0.26 | 4.1e-02 | Click! |
chrX_112554814_112554965 | Zfp711 | 45637 | 0.129146 | -0.23 | 7.4e-02 | Click! |
chrX_112603598_112603861 | Zfp711 | 545 | 0.806029 | -0.21 | 1.1e-01 | Click! |
chrX_112603027_112603443 | Zfp711 | 1039 | 0.583837 | -0.19 | 1.6e-01 | Click! |
chrX_94121312_94122461 | Zfx | 1014 | 0.565938 | 0.47 | 1.7e-04 | Click! |
chrX_94122739_94123686 | Zfx | 80 | 0.974785 | 0.32 | 1.3e-02 | Click! |
chrX_94119574_94119731 | Zfx | 3248 | 0.259999 | 0.22 | 8.7e-02 | Click! |
chrX_94131843_94131994 | Zfx | 8216 | 0.204601 | -0.20 | 1.3e-01 | Click! |
chrX_94152014_94152259 | Zfx | 28434 | 0.153302 | 0.16 | 2.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_45230983_45235468 | 36.60 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr8_84722866_84724458 | 34.03 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
655 |
0.54 |
chr4_154635108_154637998 | 32.05 |
Prdm16 |
PR domain containing 16 |
244 |
0.83 |
chr7_143005720_143007083 | 29.37 |
Tspan32 |
tetraspanin 32 |
473 |
0.68 |
chr7_141506053_141507038 | 29.31 |
Gm45416 |
predicted gene 45416 |
12058 |
0.08 |
chr11_21992790_21995427 | 28.20 |
Otx1 |
orthodenticle homeobox 1 |
7507 |
0.25 |
chr17_84185673_84188034 | 27.13 |
Zfp36l2 |
zinc finger protein 36, C3H type-like 2 |
1094 |
0.34 |
chr14_115040989_115042168 | 26.77 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1301 |
0.2 |
chr9_114562610_114564528 | 25.94 |
Trim71 |
tripartite motif-containing 71 |
800 |
0.6 |
chr4_46451134_46452573 | 25.56 |
Anp32b |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
951 |
0.47 |
chr8_121082801_121085531 | 24.83 |
Foxf1 |
forkhead box F1 |
220 |
0.71 |
chr17_85686512_85689764 | 24.59 |
Six2 |
sine oculis-related homeobox 2 |
116 |
0.96 |
chr5_64810297_64813272 | 24.39 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr2_173024069_173026002 | 23.91 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr5_124353199_124354886 | 23.49 |
Cdk2ap1 |
CDK2 (cyclin-dependent kinase 2)-associated protein 1 |
629 |
0.59 |
chr4_135152193_135153995 | 23.45 |
Runx3 |
runt related transcription factor 3 |
66 |
0.97 |
chr11_84822134_84823653 | 22.92 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
3378 |
0.15 |
chr12_73044500_73046647 | 22.69 |
Six1 |
sine oculis-related homeobox 1 |
282 |
0.92 |
chr2_38355912_38358148 | 22.68 |
Lhx2 |
LIM homeobox protein 2 |
3228 |
0.18 |
chr4_154926952_154928851 | 21.45 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
176 |
0.92 |
chr6_38874889_38876891 | 21.36 |
Hipk2 |
homeodomain interacting protein kinase 2 |
33 |
0.9 |
chr11_97439854_97442222 | 21.12 |
Arhgap23 |
Rho GTPase activating protein 23 |
4753 |
0.18 |
chr19_10015065_10016667 | 20.99 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
822 |
0.48 |
chr1_181210767_181211914 | 20.55 |
Wdr26 |
WD repeat domain 26 |
86 |
0.96 |
chr13_55210348_55211522 | 20.52 |
Nsd1 |
nuclear receptor-binding SET-domain protein 1 |
200 |
0.92 |
chr6_52259871_52261414 | 20.19 |
Hoxa13 |
homeobox A13 |
160 |
0.84 |
chr8_57320946_57324000 | 19.75 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr2_9882196_9886301 | 19.73 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr12_3806578_3808221 | 19.67 |
Dnmt3a |
DNA methyltransferase 3A |
239 |
0.92 |
chr18_35847749_35850271 | 19.50 |
Cxxc5 |
CXXC finger 5 |
5677 |
0.11 |
chr8_120292266_120293650 | 19.50 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
64502 |
0.09 |
chr17_36869615_36870619 | 19.44 |
Trim10 |
tripartite motif-containing 10 |
543 |
0.55 |
chr4_128805343_128806839 | 19.30 |
Zfp362 |
zinc finger protein 362 |
46 |
0.97 |
chr5_37826544_37829286 | 19.23 |
Msx1 |
msh homeobox 1 |
3332 |
0.25 |
chr10_62341499_62342686 | 19.03 |
Hk1 |
hexokinase 1 |
607 |
0.63 |
chr8_122546551_122549259 | 18.97 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr9_44340460_44342952 | 18.59 |
Hmbs |
hydroxymethylbilane synthase |
473 |
0.51 |
chr14_55061871_55064122 | 18.29 |
Gm20687 |
predicted gene 20687 |
7503 |
0.08 |
chr7_45523041_45524800 | 18.25 |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
151 |
0.85 |
chr6_23247289_23250418 | 18.14 |
Fezf1 |
Fez family zinc finger 1 |
491 |
0.76 |
chr11_94327571_94328948 | 18.02 |
Ankrd40 |
ankyrin repeat domain 40 |
5 |
0.97 |
chr5_123138345_123140456 | 17.94 |
AI480526 |
expressed sequence AI480526 |
53 |
0.85 |
chr2_127369985_127371247 | 17.87 |
Adra2b |
adrenergic receptor, alpha 2b |
7330 |
0.15 |
chr11_102360845_102363484 | 17.70 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr7_143007094_143009025 | 17.70 |
Tspan32os |
tetraspanin 32, opposite strand |
26 |
0.96 |
chr2_172549301_172551909 | 17.63 |
Tfap2c |
transcription factor AP-2, gamma |
48 |
0.98 |
chr4_151994846_151996125 | 17.53 |
Phf13 |
PHD finger protein 13 |
773 |
0.47 |
chr2_153528339_153529939 | 17.51 |
Nol4l |
nucleolar protein 4-like |
832 |
0.63 |
chr11_116076531_116078496 | 17.26 |
Unc13d |
unc-13 homolog D |
77 |
0.94 |
chr2_30771310_30772478 | 17.22 |
1700001O22Rik |
RIKEN cDNA 1700001O22 gene |
24770 |
0.11 |
chr15_76666348_76670076 | 17.14 |
Foxh1 |
forkhead box H1 |
1590 |
0.15 |
chr17_56424927_56425952 | 17.02 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
22 |
0.97 |
chr7_99594627_99596228 | 16.96 |
Arrb1 |
arrestin, beta 1 |
804 |
0.48 |
chr2_33639069_33641423 | 16.86 |
Lmx1b |
LIM homeobox transcription factor 1 beta |
234 |
0.85 |
chr7_133700764_133701966 | 16.66 |
Uros |
uroporphyrinogen III synthase |
1173 |
0.35 |
chr7_66109343_66110813 | 16.64 |
Chsy1 |
chondroitin sulfate synthase 1 |
563 |
0.64 |
chr4_141536335_141538488 | 16.54 |
Spen |
spen family transcription repressor |
842 |
0.51 |
chr19_46304366_46306224 | 16.49 |
4833438C02Rik |
RIKEN cDNA 4833438C02 gene |
310 |
0.52 |
chr10_69351583_69352885 | 16.31 |
Cdk1 |
cyclin-dependent kinase 1 |
669 |
0.68 |
chr12_84192576_84193882 | 16.19 |
Elmsan1 |
ELM2 and Myb/SANT-like domain containing 1 |
786 |
0.46 |
chr10_81497570_81499812 | 16.16 |
S1pr4 |
sphingosine-1-phosphate receptor 4 |
1441 |
0.16 |
chr6_83068298_83071797 | 16.03 |
Tlx2 |
T cell leukemia, homeobox 2 |
178 |
0.81 |
chr6_119479570_119481166 | 15.95 |
Fbxl14 |
F-box and leucine-rich repeat protein 14 |
700 |
0.7 |
chr12_111166036_111167450 | 15.94 |
Traf3 |
TNF receptor-associated factor 3 |
195 |
0.94 |
chr8_122296202_122297239 | 15.92 |
Zfpm1 |
zinc finger protein, multitype 1 |
10600 |
0.14 |
chr3_9608603_9610121 | 15.84 |
Zfp704 |
zinc finger protein 704 |
723 |
0.73 |
chr15_96286968_96288193 | 15.81 |
Arid2 |
AT rich interactive domain 2 (ARID, RFX-like) |
7 |
0.98 |
chr5_119669544_119672401 | 15.56 |
Tbx3 |
T-box 3 |
46 |
0.85 |
chr2_93644408_93646515 | 15.39 |
Alx4 |
aristaless-like homeobox 4 |
3073 |
0.32 |
chr5_121711876_121713175 | 15.38 |
Atxn2 |
ataxin 2 |
444 |
0.71 |
chr5_115947488_115948141 | 15.37 |
Cit |
citron |
2517 |
0.25 |
chr15_38077521_38078812 | 15.37 |
Ubr5 |
ubiquitin protein ligase E3 component n-recognin 5 |
259 |
0.83 |
chr5_35160468_35161280 | 15.36 |
Lrpap1 |
low density lipoprotein receptor-related protein associated protein 1 |
55108 |
0.11 |
chr7_111081451_111082886 | 15.35 |
Eif4g2 |
eukaryotic translation initiation factor 4, gamma 2 |
27 |
0.97 |
chr8_88301330_88302008 | 15.29 |
Adcy7 |
adenylate cyclase 7 |
1290 |
0.46 |
chr15_82340829_82341556 | 15.19 |
Pheta2 |
PH domain containing endocytic trafficking adaptor 2 |
13 |
0.7 |
chr8_123041014_123042226 | 15.17 |
Ankrd11 |
ankyrin repeat domain 11 |
400 |
0.64 |
chr7_16885022_16886331 | 15.17 |
2700080J24Rik |
RIKEN cDNA 2700080J24 gene |
5391 |
0.09 |
chr17_27556596_27558077 | 15.12 |
Hmga1 |
high mobility group AT-hook 1 |
641 |
0.37 |
chr4_133752701_133753843 | 15.09 |
Arid1a |
AT rich interactive domain 1A (SWI-like) |
339 |
0.85 |
chr11_58008955_58010139 | 15.02 |
Larp1 |
La ribonucleoprotein domain family, member 1 |
483 |
0.77 |
chr1_38128773_38130359 | 14.98 |
Rev1 |
REV1, DNA directed polymerase |
96 |
0.96 |
chr6_136470222_136471348 | 14.97 |
Gm6728 |
predicted gene 6728 |
16401 |
0.12 |
chr4_132072958_132073606 | 14.96 |
Epb41 |
erythrocyte membrane protein band 4.1 |
1185 |
0.28 |
chr7_4741899_4743098 | 14.94 |
Kmt5c |
lysine methyltransferase 5C |
44 |
0.93 |
chr1_132366786_132367836 | 14.92 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
239 |
0.89 |
chr4_123663941_123665300 | 14.82 |
Macf1 |
microtubule-actin crosslinking factor 1 |
132 |
0.92 |
chr11_22000607_22002265 | 14.63 |
Otx1 |
orthodenticle homeobox 1 |
179 |
0.96 |
chr9_106885777_106887024 | 14.59 |
Rbm15b |
RNA binding motif protein 15B |
781 |
0.48 |
chr7_13024350_13025809 | 14.57 |
Trim28 |
tripartite motif-containing 28 |
679 |
0.45 |
chr4_132210833_132211995 | 14.54 |
Ythdf2 |
YTH N6-methyladenosine RNA binding protein 2 |
605 |
0.52 |
chr11_117779316_117780928 | 14.49 |
Tmc6 |
transmembrane channel-like gene family 6 |
472 |
0.61 |
chr2_24385363_24386049 | 14.48 |
Psd4 |
pleckstrin and Sec7 domain containing 4 |
353 |
0.84 |
chr11_87756102_87757558 | 14.43 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr14_69283473_69284973 | 14.40 |
Gm31748 |
predicted gene, 31748 |
127 |
0.72 |
chr2_20967742_20969334 | 14.37 |
Arhgap21 |
Rho GTPase activating protein 21 |
12 |
0.91 |
chr3_99255907_99257438 | 14.32 |
Tbx15 |
T-box 15 |
2912 |
0.22 |
chr11_96004600_96005875 | 14.24 |
Gm29202 |
predicted gene 29202 |
652 |
0.35 |
chr3_95172192_95174377 | 14.24 |
Sema6c |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C |
2479 |
0.12 |
chr5_107724563_107727169 | 14.16 |
Gfi1 |
growth factor independent 1 transcription repressor |
61 |
0.88 |
chr12_110977009_110977496 | 14.15 |
Ankrd9 |
ankyrin repeat domain 9 |
1003 |
0.41 |
chr2_167688724_167690153 | 14.14 |
Tmem189 |
transmembrane protein 189 |
384 |
0.52 |
chr15_73183514_73184891 | 14.13 |
Ago2 |
argonaute RISC catalytic subunit 2 |
733 |
0.68 |
chr5_137531422_137533165 | 14.11 |
Gm17112 |
predicted gene 17112 |
130 |
0.69 |
chr2_144010049_144010845 | 13.95 |
Rrbp1 |
ribosome binding protein 1 |
816 |
0.62 |
chr9_21029266_21030734 | 13.91 |
Icam4 |
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
546 |
0.46 |
chr5_114969022_114970855 | 13.90 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
18 |
0.91 |
chr10_7955099_7956159 | 13.83 |
Tab2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
264 |
0.93 |
chr11_97434598_97436859 | 13.75 |
Arhgap23 |
Rho GTPase activating protein 23 |
557 |
0.73 |
chr11_12035779_12037364 | 13.73 |
Grb10 |
growth factor receptor bound protein 10 |
830 |
0.66 |
chr2_154568646_154569144 | 13.73 |
E2f1 |
E2F transcription factor 1 |
825 |
0.45 |
chr11_120948479_120950230 | 13.72 |
Slc16a3 |
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
273 |
0.84 |
chrX_137118132_137120673 | 13.70 |
Esx1 |
extraembryonic, spermatogenesis, homeobox 1 |
769 |
0.36 |
chr10_80570596_80572042 | 13.62 |
Klf16 |
Kruppel-like factor 16 |
6002 |
0.08 |
chr13_55830047_55831334 | 13.61 |
Pitx1 |
paired-like homeodomain transcription factor 1 |
735 |
0.57 |
chr18_75384437_75388058 | 13.60 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr13_91461118_91462460 | 13.57 |
Ssbp2 |
single-stranded DNA binding protein 2 |
608 |
0.81 |
chr17_27203338_27204414 | 13.49 |
Lemd2 |
LEM domain containing 2 |
200 |
0.88 |
chr6_52252411_52254268 | 13.47 |
9530018H14Rik |
RIKEN cDNA 9530018H14 gene |
4121 |
0.07 |
chr3_89136417_89137539 | 13.40 |
Pklr |
pyruvate kinase liver and red blood cell |
355 |
0.69 |
chr8_122550647_122551663 | 13.38 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
174 |
0.89 |
chr9_63756717_63758746 | 13.31 |
Smad3 |
SMAD family member 3 |
263 |
0.93 |
chr10_82762742_82763996 | 13.29 |
Nfyb |
nuclear transcription factor-Y beta |
277 |
0.86 |
chr13_29983771_29984979 | 13.25 |
E2f3 |
E2F transcription factor 3 |
16 |
0.98 |
chr4_117494219_117495542 | 13.20 |
Rnf220 |
ring finger protein 220 |
131 |
0.93 |
chr10_81429822_81431152 | 13.19 |
Nfic |
nuclear factor I/C |
518 |
0.52 |
chr7_24370279_24371432 | 13.18 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
517 |
0.59 |
chr4_136177602_136178758 | 13.17 |
E2f2 |
E2F transcription factor 2 |
2603 |
0.21 |
chr3_103279802_103280896 | 13.16 |
Trim33 |
tripartite motif-containing 33 |
470 |
0.79 |
chr9_120933509_120934927 | 13.14 |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
400 |
0.74 |
chr5_31251110_31252754 | 13.14 |
Krtcap3 |
keratinocyte associated protein 3 |
5 |
0.93 |
chr16_94570322_94571191 | 13.09 |
Dyrk1a |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a |
108 |
0.97 |
chr5_65696990_65697914 | 13.08 |
Pds5a |
PDS5 cohesin associated factor A |
404 |
0.75 |
chr1_58393178_58393943 | 13.02 |
Bzw1 |
basic leucine zipper and W2 domains 1 |
90 |
0.95 |
chr11_45854563_45855051 | 12.99 |
Clint1 |
clathrin interactor 1 |
2843 |
0.21 |
chr10_42581935_42584872 | 12.97 |
Nr2e1 |
nuclear receptor subfamily 2, group E, member 1 |
229 |
0.69 |
chr4_127021337_127022939 | 12.97 |
Sfpq |
splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated) |
814 |
0.48 |
chr15_102470640_102471848 | 12.92 |
Pcbp2 |
poly(rC) binding protein 2 |
5 |
0.95 |
chr1_177442331_177443767 | 12.91 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
167 |
0.57 |
chr6_30172641_30174725 | 12.90 |
Rncr4 |
retina expressed non-coding RNA 4 |
790 |
0.51 |
chr1_184731287_184732512 | 12.88 |
Hlx |
H2.0-like homeobox |
301 |
0.86 |
chr15_83593044_83593682 | 12.84 |
Ttll12 |
tubulin tyrosine ligase-like family, member 12 |
1794 |
0.26 |
chr11_69364290_69367679 | 12.80 |
Chd3 |
chromodomain helicase DNA binding protein 3 |
1205 |
0.24 |
chr12_56699459_56700760 | 12.79 |
Pax9 |
paired box 9 |
4380 |
0.18 |
chr6_29694287_29695938 | 12.78 |
Tspan33 |
tetraspanin 33 |
878 |
0.58 |
chr13_37826269_37827832 | 12.74 |
Rreb1 |
ras responsive element binding protein 1 |
118 |
0.96 |
chr15_103013757_103015908 | 12.73 |
Mir615 |
microRNA 615 |
78 |
0.91 |
chr4_131920577_131922124 | 12.70 |
Tmem200b |
transmembrane protein 200B |
150 |
0.52 |
chr14_73325134_73326479 | 12.68 |
Rb1 |
RB transcriptional corepressor 1 |
16 |
0.98 |
chr6_120037117_120038604 | 12.66 |
Wnk1 |
WNK lysine deficient protein kinase 1 |
201 |
0.93 |
chr9_58246669_58247815 | 12.55 |
Pml |
promyelocytic leukemia |
2381 |
0.19 |
chr15_81585550_81586926 | 12.47 |
Ep300 |
E1A binding protein p300 |
18 |
0.58 |
chr2_161108086_161108991 | 12.46 |
Chd6 |
chromodomain helicase DNA binding protein 6 |
466 |
0.66 |
chr12_24711174_24711896 | 12.42 |
Rrm2 |
ribonucleotide reductase M2 |
2506 |
0.21 |
chr2_163054662_163055903 | 12.41 |
Mybl2 |
myeloblastosis oncogene-like 2 |
595 |
0.64 |
chr4_115057577_115059724 | 12.40 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
839 |
0.56 |
chr7_127090806_127091953 | 12.38 |
AI467606 |
expressed sequence AI467606 |
20 |
0.93 |
chr2_179976018_179976658 | 12.32 |
Taf4 |
TATA-box binding protein associated factor 4 |
308 |
0.51 |
chr7_142576289_142578620 | 12.29 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr16_4213418_4213966 | 12.24 |
Crebbp |
CREB binding protein |
279 |
0.9 |
chr7_18957439_18958650 | 12.23 |
Nanos2 |
nanos C2HC-type zinc finger 2 |
29356 |
0.06 |
chr1_59482170_59483669 | 12.23 |
Fzd7 |
frizzled class receptor 7 |
495 |
0.73 |
chr17_25961783_25962611 | 12.22 |
Capn15 |
calpain 15 |
1563 |
0.17 |
chr7_19691393_19692666 | 12.22 |
Apoc1 |
apolipoprotein C-I |
462 |
0.59 |
chr19_46501801_46503049 | 12.22 |
Trim8 |
tripartite motif-containing 8 |
723 |
0.61 |
chr2_74697508_74699145 | 12.21 |
Hoxd9 |
homeobox D9 |
599 |
0.31 |
chr9_82974428_82975413 | 12.21 |
Phip |
pleckstrin homology domain interacting protein |
488 |
0.83 |
chr11_69947014_69948171 | 12.20 |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
382 |
0.6 |
chr15_83169748_83171160 | 12.18 |
Cyb5r3 |
cytochrome b5 reductase 3 |
52 |
0.95 |
chr19_6363442_6364454 | 12.18 |
Sf1 |
splicing factor 1 |
15 |
0.69 |
chr11_102145120_102148094 | 12.15 |
Nags |
N-acetylglutamate synthase |
241 |
0.58 |
chr17_45594287_45595840 | 12.14 |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
439 |
0.67 |
chr9_98954965_98956948 | 12.10 |
Foxl2os |
forkhead box L2, opposite strand |
657 |
0.38 |
chr8_121116214_121118487 | 12.08 |
Foxc2 |
forkhead box C2 |
1179 |
0.35 |
chr12_49382714_49384085 | 12.06 |
Foxg1 |
forkhead box G1 |
392 |
0.72 |
chr5_139550965_139553757 | 12.04 |
Uncx |
UNC homeobox |
8463 |
0.18 |
chr13_46726690_46727864 | 12.03 |
Nup153 |
nucleoporin 153 |
663 |
0.68 |
chr4_115059803_115061295 | 11.99 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
1041 |
0.47 |
chr10_45485502_45486858 | 11.95 |
Lin28b |
lin-28 homolog B (C. elegans) |
215 |
0.95 |
chr4_154024404_154026596 | 11.95 |
Smim1 |
small integral membrane protein 1 |
116 |
0.93 |
chr7_141196800_141198076 | 11.93 |
Lrrc56 |
leucine rich repeat containing 56 |
504 |
0.54 |
chr2_118901607_118902784 | 11.92 |
Bahd1 |
bromo adjacent homology domain containing 1 |
742 |
0.58 |
chr19_41263116_41264334 | 11.92 |
Tm9sf3 |
transmembrane 9 superfamily member 3 |
255 |
0.94 |
chr8_8689293_8690487 | 11.91 |
Arglu1 |
arginine and glutamate rich 1 |
214 |
0.54 |
chr11_85833878_85836704 | 11.90 |
Tbx2 |
T-box 2 |
2740 |
0.17 |
chr5_24426725_24429282 | 11.89 |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
205 |
0.83 |
chr7_142082140_142083011 | 11.85 |
Gm25416 |
predicted gene, 25416 |
4138 |
0.1 |
chr12_57542139_57543972 | 11.83 |
Foxa1 |
forkhead box A1 |
3066 |
0.2 |
chr8_117256613_117257991 | 11.83 |
Cmip |
c-Maf inducing protein |
185 |
0.96 |
chr13_98814816_98815870 | 11.82 |
Fcho2 |
FCH domain only 2 |
106 |
0.93 |
chr5_121544853_121545966 | 11.81 |
Adam1a |
a disintegrin and metallopeptidase domain 1a |
73 |
0.39 |
chr8_70493071_70496051 | 11.81 |
Crlf1 |
cytokine receptor-like factor 1 |
1200 |
0.25 |
chr7_28796055_28797204 | 11.81 |
Rinl |
Ras and Rab interactor-like |
309 |
0.76 |
chr5_28457868_28460972 | 11.80 |
9530036O11Rik |
RIKEN cDNA 9530036O11Rik |
1146 |
0.51 |
chr9_107975554_107976970 | 11.80 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
46 |
0.91 |
chr11_117782674_117783995 | 11.74 |
Tmc8 |
transmembrane channel-like gene family 8 |
676 |
0.39 |
chr1_30872791_30873874 | 11.74 |
Phf3 |
PHD finger protein 3 |
80 |
0.97 |
chrX_68678706_68679769 | 11.71 |
Fmr1 |
fragile X mental retardation 1 |
420 |
0.82 |
chr11_60105066_60106425 | 11.69 |
Rai1 |
retinoic acid induced 1 |
568 |
0.71 |
chr4_46038779_46040179 | 11.69 |
Tmod1 |
tropomodulin 1 |
270 |
0.92 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.7 | 59.1 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
14.6 | 29.2 | GO:0010159 | specification of organ position(GO:0010159) |
13.4 | 26.8 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
12.4 | 49.7 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
10.9 | 43.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
10.5 | 31.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
9.4 | 18.8 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
9.3 | 27.9 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
9.0 | 35.9 | GO:0048625 | myoblast fate commitment(GO:0048625) |
8.9 | 26.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
8.6 | 25.9 | GO:0002432 | granuloma formation(GO:0002432) |
8.5 | 42.5 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
8.4 | 8.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
8.3 | 24.8 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
8.2 | 24.7 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
8.0 | 32.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
7.9 | 7.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
7.7 | 30.8 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
7.7 | 23.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
7.4 | 22.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
7.3 | 14.7 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
7.3 | 14.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
7.2 | 28.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
7.0 | 21.0 | GO:0002930 | trabecular meshwork development(GO:0002930) |
6.9 | 13.8 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
6.9 | 20.7 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
6.9 | 13.7 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
6.8 | 20.5 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
6.8 | 67.8 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
6.6 | 26.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
6.6 | 19.9 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
6.6 | 6.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
6.6 | 52.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
6.5 | 26.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
6.4 | 19.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
6.4 | 19.1 | GO:0000087 | mitotic M phase(GO:0000087) |
6.3 | 25.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
6.3 | 18.9 | GO:0061010 | gall bladder development(GO:0061010) |
6.3 | 18.8 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
6.2 | 18.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
6.2 | 24.7 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
6.2 | 18.5 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
6.1 | 18.4 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
6.1 | 6.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
6.1 | 12.2 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
6.1 | 6.1 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
6.0 | 24.0 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
6.0 | 6.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
6.0 | 11.9 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
5.9 | 17.8 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
5.9 | 35.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
5.8 | 145.8 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
5.7 | 17.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
5.7 | 22.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
5.5 | 49.7 | GO:0060896 | neural plate pattern specification(GO:0060896) |
5.5 | 16.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
5.4 | 21.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
5.4 | 16.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
5.3 | 15.9 | GO:0045472 | response to ether(GO:0045472) |
5.3 | 15.9 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
5.3 | 36.9 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
5.3 | 26.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
5.2 | 15.7 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
5.2 | 10.4 | GO:0051101 | regulation of DNA binding(GO:0051101) |
5.2 | 15.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
5.2 | 15.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
5.2 | 26.0 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
5.2 | 25.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
5.2 | 25.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
5.2 | 31.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
5.1 | 20.5 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
5.1 | 35.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
5.1 | 5.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
5.1 | 10.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
5.1 | 5.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
5.1 | 35.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
5.0 | 40.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
5.0 | 15.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
5.0 | 64.9 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
5.0 | 24.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
5.0 | 14.9 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
4.9 | 24.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
4.9 | 19.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
4.9 | 24.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
4.8 | 4.8 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
4.8 | 14.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
4.8 | 23.9 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
4.8 | 9.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
4.7 | 14.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
4.7 | 23.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
4.7 | 14.1 | GO:0044027 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
4.7 | 18.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
4.7 | 4.7 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
4.6 | 4.6 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
4.6 | 13.9 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
4.6 | 9.3 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
4.6 | 9.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
4.6 | 4.6 | GO:0035973 | aggrephagy(GO:0035973) |
4.6 | 9.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
4.6 | 9.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
4.5 | 13.6 | GO:0036394 | amylase secretion(GO:0036394) |
4.5 | 36.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
4.5 | 22.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
4.5 | 13.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
4.4 | 4.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
4.4 | 17.6 | GO:0030578 | PML body organization(GO:0030578) |
4.4 | 8.8 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
4.4 | 13.2 | GO:0030952 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
4.4 | 8.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
4.4 | 30.6 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
4.3 | 30.4 | GO:0036089 | cleavage furrow formation(GO:0036089) |
4.3 | 26.0 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
4.3 | 13.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
4.3 | 34.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
4.3 | 21.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
4.3 | 4.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
4.2 | 12.7 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
4.2 | 8.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
4.2 | 38.0 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
4.2 | 25.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
4.2 | 8.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
4.2 | 25.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
4.2 | 4.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
4.2 | 8.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
4.1 | 24.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
4.1 | 12.4 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
4.1 | 24.8 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
4.1 | 8.3 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
4.1 | 12.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
4.1 | 8.2 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
4.1 | 8.2 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
4.1 | 12.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
4.1 | 36.9 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
4.1 | 12.3 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
4.1 | 16.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
4.1 | 12.2 | GO:0001555 | oocyte growth(GO:0001555) |
4.1 | 20.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
4.0 | 20.2 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
4.0 | 8.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
4.0 | 4.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
4.0 | 8.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
4.0 | 16.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
4.0 | 8.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
4.0 | 31.8 | GO:0031498 | chromatin disassembly(GO:0031498) |
4.0 | 7.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
3.9 | 15.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
3.9 | 43.1 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
3.9 | 7.8 | GO:0051177 | meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
3.9 | 15.6 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
3.9 | 15.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
3.9 | 11.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
3.9 | 3.9 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
3.9 | 7.8 | GO:0014029 | neural crest formation(GO:0014029) |
3.9 | 7.8 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
3.9 | 11.6 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
3.9 | 11.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
3.9 | 15.4 | GO:0007296 | vitellogenesis(GO:0007296) |
3.8 | 7.7 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
3.8 | 11.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
3.8 | 30.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
3.8 | 11.5 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
3.8 | 19.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
3.8 | 7.6 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
3.8 | 7.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
3.8 | 3.8 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
3.8 | 3.8 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
3.8 | 15.0 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
3.7 | 7.5 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
3.7 | 29.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
3.7 | 7.4 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
3.7 | 11.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
3.7 | 11.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
3.7 | 11.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
3.7 | 14.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
3.7 | 22.0 | GO:0009299 | mRNA transcription(GO:0009299) |
3.7 | 18.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
3.7 | 25.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
3.7 | 7.3 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
3.6 | 25.5 | GO:0001842 | neural fold formation(GO:0001842) |
3.6 | 25.5 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
3.6 | 10.9 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
3.6 | 7.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
3.6 | 3.6 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
3.6 | 21.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
3.6 | 10.8 | GO:0042117 | monocyte activation(GO:0042117) |
3.6 | 18.0 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
3.6 | 10.8 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
3.6 | 17.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
3.6 | 28.4 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
3.5 | 14.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
3.5 | 10.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
3.5 | 17.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
3.5 | 7.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
3.5 | 10.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
3.5 | 3.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
3.5 | 7.0 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
3.5 | 24.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
3.5 | 21.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
3.5 | 10.5 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
3.5 | 24.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
3.5 | 10.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
3.5 | 3.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
3.5 | 10.4 | GO:0006742 | NADP catabolic process(GO:0006742) |
3.5 | 13.9 | GO:0032264 | IMP salvage(GO:0032264) |
3.5 | 13.9 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
3.5 | 31.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
3.5 | 13.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
3.5 | 3.5 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
3.5 | 13.8 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
3.5 | 6.9 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
3.4 | 3.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
3.4 | 17.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
3.4 | 6.9 | GO:0061511 | centriole elongation(GO:0061511) |
3.4 | 3.4 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
3.4 | 6.8 | GO:0043173 | nucleotide salvage(GO:0043173) |
3.4 | 27.4 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
3.4 | 17.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
3.4 | 6.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
3.4 | 10.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
3.4 | 3.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
3.4 | 17.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
3.4 | 6.8 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
3.4 | 10.2 | GO:0019532 | oxalate transport(GO:0019532) |
3.4 | 20.3 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
3.4 | 16.9 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
3.4 | 10.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
3.4 | 10.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
3.4 | 3.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
3.3 | 16.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
3.3 | 3.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
3.3 | 13.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
3.3 | 10.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
3.3 | 6.6 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
3.3 | 19.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
3.3 | 19.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
3.3 | 29.6 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
3.3 | 13.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
3.3 | 6.6 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
3.3 | 3.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
3.3 | 3.3 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
3.3 | 3.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
3.3 | 9.8 | GO:0060033 | anatomical structure regression(GO:0060033) |
3.3 | 22.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
3.3 | 22.8 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
3.2 | 13.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
3.2 | 3.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
3.2 | 22.6 | GO:0097421 | liver regeneration(GO:0097421) |
3.2 | 9.7 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
3.2 | 6.4 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
3.2 | 9.6 | GO:0006562 | proline catabolic process(GO:0006562) |
3.2 | 9.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
3.2 | 28.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
3.2 | 6.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
3.2 | 34.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
3.2 | 15.8 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
3.2 | 12.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
3.2 | 34.7 | GO:0048821 | erythrocyte development(GO:0048821) |
3.1 | 12.6 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
3.1 | 3.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
3.1 | 6.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
3.1 | 9.4 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
3.1 | 12.4 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
3.1 | 52.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
3.1 | 31.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
3.1 | 27.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
3.1 | 9.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
3.1 | 18.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
3.1 | 18.3 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
3.0 | 12.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
3.0 | 9.1 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
3.0 | 30.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
3.0 | 9.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
3.0 | 18.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
3.0 | 12.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
3.0 | 3.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
3.0 | 9.0 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
3.0 | 27.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
3.0 | 9.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
3.0 | 35.8 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
3.0 | 17.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
3.0 | 5.9 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
3.0 | 8.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
3.0 | 3.0 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
3.0 | 41.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
3.0 | 3.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
3.0 | 8.9 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
2.9 | 8.8 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
2.9 | 8.8 | GO:2000973 | pro-B cell differentiation(GO:0002328) regulation of pro-B cell differentiation(GO:2000973) |
2.9 | 14.7 | GO:0015879 | carnitine transport(GO:0015879) |
2.9 | 8.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
2.9 | 11.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
2.9 | 11.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
2.9 | 2.9 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
2.9 | 8.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.9 | 5.8 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
2.9 | 14.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
2.9 | 5.8 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
2.9 | 34.8 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
2.9 | 8.7 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
2.9 | 2.9 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
2.9 | 8.7 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
2.9 | 52.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
2.9 | 2.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
2.9 | 8.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.9 | 23.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
2.9 | 17.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
2.9 | 8.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
2.9 | 2.9 | GO:0060591 | chondroblast differentiation(GO:0060591) |
2.9 | 2.9 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.9 | 25.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
2.8 | 5.7 | GO:0072718 | response to cisplatin(GO:0072718) |
2.8 | 8.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
2.8 | 5.7 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
2.8 | 8.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
2.8 | 2.8 | GO:1903416 | response to glycoside(GO:1903416) |
2.8 | 8.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
2.8 | 11.3 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
2.8 | 16.9 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
2.8 | 22.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
2.8 | 16.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
2.8 | 5.6 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
2.8 | 2.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
2.8 | 16.8 | GO:0060613 | fat pad development(GO:0060613) |
2.8 | 2.8 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
2.8 | 8.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
2.8 | 11.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
2.8 | 8.3 | GO:2000562 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
2.8 | 13.9 | GO:0021764 | amygdala development(GO:0021764) |
2.8 | 2.8 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
2.8 | 11.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
2.8 | 2.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
2.8 | 11.0 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
2.8 | 13.8 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
2.7 | 5.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
2.7 | 8.2 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
2.7 | 19.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
2.7 | 11.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
2.7 | 13.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
2.7 | 10.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
2.7 | 5.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
2.7 | 21.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
2.7 | 10.9 | GO:0018101 | protein citrullination(GO:0018101) |
2.7 | 51.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
2.7 | 8.2 | GO:0070375 | ERK5 cascade(GO:0070375) |
2.7 | 2.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.7 | 5.4 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
2.7 | 2.7 | GO:0061724 | lipophagy(GO:0061724) |
2.7 | 32.4 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
2.7 | 2.7 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
2.7 | 21.6 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
2.7 | 5.4 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
2.7 | 5.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
2.7 | 21.5 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
2.7 | 2.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
2.7 | 8.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
2.7 | 53.7 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
2.7 | 2.7 | GO:0010464 | regulation of mesenchymal cell proliferation(GO:0010464) |
2.7 | 5.3 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
2.7 | 16.0 | GO:0032782 | bile acid secretion(GO:0032782) |
2.7 | 16.0 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
2.7 | 10.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
2.7 | 5.3 | GO:0007035 | vacuolar acidification(GO:0007035) |
2.7 | 8.0 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
2.6 | 7.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
2.6 | 10.6 | GO:0009414 | response to water deprivation(GO:0009414) |
2.6 | 15.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
2.6 | 13.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
2.6 | 10.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
2.6 | 15.8 | GO:0006477 | protein sulfation(GO:0006477) |
2.6 | 7.9 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
2.6 | 7.9 | GO:0018343 | protein farnesylation(GO:0018343) |
2.6 | 5.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
2.6 | 7.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
2.6 | 7.9 | GO:0060023 | soft palate development(GO:0060023) |
2.6 | 5.2 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
2.6 | 2.6 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
2.6 | 5.2 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
2.6 | 7.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
2.6 | 2.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
2.6 | 7.8 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
2.6 | 15.5 | GO:0048664 | neuron fate determination(GO:0048664) |
2.6 | 2.6 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
2.6 | 2.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
2.6 | 10.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
2.6 | 15.4 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
2.6 | 5.1 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
2.6 | 5.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
2.5 | 7.6 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
2.5 | 7.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
2.5 | 5.1 | GO:0019081 | viral translation(GO:0019081) viral translational termination-reinitiation(GO:0075525) |
2.5 | 12.7 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
2.5 | 17.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
2.5 | 7.6 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.5 | 12.7 | GO:0034063 | stress granule assembly(GO:0034063) |
2.5 | 7.6 | GO:0031577 | spindle checkpoint(GO:0031577) |
2.5 | 5.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
2.5 | 22.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
2.5 | 17.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
2.5 | 15.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
2.5 | 10.1 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
2.5 | 2.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
2.5 | 5.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
2.5 | 5.0 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
2.5 | 47.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
2.5 | 2.5 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
2.5 | 12.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
2.5 | 2.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
2.5 | 2.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
2.5 | 7.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.5 | 7.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
2.5 | 20.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
2.5 | 2.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
2.5 | 7.5 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
2.5 | 19.9 | GO:0038092 | nodal signaling pathway(GO:0038092) |
2.5 | 37.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
2.5 | 4.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
2.5 | 9.9 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
2.5 | 7.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
2.5 | 22.2 | GO:0060914 | heart formation(GO:0060914) |
2.5 | 2.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.5 | 22.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.5 | 2.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
2.4 | 22.0 | GO:0003417 | growth plate cartilage development(GO:0003417) |
2.4 | 2.4 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
2.4 | 2.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
2.4 | 14.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
2.4 | 14.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
2.4 | 4.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.4 | 4.9 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
2.4 | 7.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
2.4 | 9.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
2.4 | 7.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
2.4 | 7.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
2.4 | 7.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.4 | 21.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
2.4 | 14.5 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
2.4 | 9.6 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
2.4 | 67.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
2.4 | 2.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
2.4 | 2.4 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
2.4 | 35.9 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
2.4 | 21.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
2.4 | 2.4 | GO:0036258 | multivesicular body assembly(GO:0036258) |
2.4 | 9.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
2.4 | 2.4 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
2.4 | 7.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
2.4 | 14.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
2.4 | 2.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
2.4 | 4.7 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
2.4 | 23.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
2.4 | 2.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
2.4 | 9.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
2.4 | 4.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.3 | 7.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
2.3 | 2.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.3 | 18.8 | GO:0051383 | kinetochore organization(GO:0051383) |
2.3 | 51.5 | GO:0051306 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) metaphase/anaphase transition of cell cycle(GO:0044784) mitotic sister chromatid separation(GO:0051306) |
2.3 | 4.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
2.3 | 7.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
2.3 | 2.3 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
2.3 | 11.7 | GO:2000826 | regulation of heart morphogenesis(GO:2000826) |
2.3 | 9.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
2.3 | 60.5 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
2.3 | 11.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
2.3 | 67.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
2.3 | 6.9 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
2.3 | 50.9 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
2.3 | 4.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
2.3 | 23.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
2.3 | 23.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
2.3 | 4.6 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
2.3 | 2.3 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
2.3 | 13.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
2.3 | 2.3 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
2.3 | 4.6 | GO:0051036 | regulation of endosome size(GO:0051036) |
2.3 | 4.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.3 | 32.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
2.3 | 25.2 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
2.3 | 22.8 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
2.3 | 9.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
2.3 | 2.3 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
2.3 | 6.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
2.3 | 4.5 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
2.3 | 2.3 | GO:0060534 | trachea cartilage development(GO:0060534) |
2.3 | 11.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.3 | 6.8 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
2.2 | 9.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
2.2 | 31.4 | GO:0001893 | maternal placenta development(GO:0001893) |
2.2 | 9.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
2.2 | 9.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
2.2 | 6.7 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
2.2 | 11.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) cellular response to vitamin D(GO:0071305) |
2.2 | 24.6 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
2.2 | 6.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.2 | 8.9 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
2.2 | 11.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
2.2 | 4.4 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
2.2 | 8.9 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
2.2 | 15.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
2.2 | 31.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
2.2 | 4.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
2.2 | 31.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
2.2 | 15.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
2.2 | 6.6 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
2.2 | 2.2 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) |
2.2 | 2.2 | GO:1990182 | exosomal secretion(GO:1990182) |
2.2 | 21.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
2.2 | 8.8 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
2.2 | 15.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.2 | 8.7 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
2.2 | 6.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
2.2 | 8.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
2.2 | 10.9 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
2.2 | 2.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.2 | 13.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
2.2 | 6.5 | GO:0070828 | heterochromatin organization(GO:0070828) |
2.2 | 8.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
2.2 | 17.4 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
2.2 | 4.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
2.2 | 2.2 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
2.2 | 6.5 | GO:0046104 | thymidine metabolic process(GO:0046104) |
2.2 | 4.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
2.2 | 10.8 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
2.2 | 10.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
2.2 | 2.2 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
2.2 | 2.2 | GO:0045829 | negative regulation of isotype switching(GO:0045829) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
2.2 | 8.6 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
2.2 | 6.5 | GO:0061450 | trophoblast cell migration(GO:0061450) |
2.2 | 2.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
2.1 | 2.1 | GO:0061055 | myotome development(GO:0061055) |
2.1 | 42.9 | GO:0060325 | face morphogenesis(GO:0060325) |
2.1 | 12.9 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
2.1 | 8.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
2.1 | 4.3 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.1 | 2.1 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
2.1 | 6.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
2.1 | 8.5 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
2.1 | 40.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
2.1 | 12.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
2.1 | 6.3 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
2.1 | 4.2 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
2.1 | 10.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
2.1 | 6.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.1 | 12.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
2.1 | 2.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
2.1 | 4.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
2.1 | 25.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
2.1 | 6.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
2.1 | 12.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
2.1 | 4.2 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
2.1 | 6.3 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
2.1 | 8.3 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
2.1 | 2.1 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
2.1 | 8.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
2.1 | 2.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
2.1 | 2.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
2.1 | 10.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
2.1 | 6.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
2.1 | 8.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
2.1 | 6.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
2.0 | 2.0 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
2.0 | 4.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
2.0 | 6.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
2.0 | 8.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
2.0 | 4.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
2.0 | 2.0 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
2.0 | 12.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
2.0 | 16.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
2.0 | 4.0 | GO:0045730 | respiratory burst(GO:0045730) |
2.0 | 2.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
2.0 | 8.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
2.0 | 6.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
2.0 | 8.1 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
2.0 | 6.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
2.0 | 8.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
2.0 | 2.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
2.0 | 6.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
2.0 | 6.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
2.0 | 8.0 | GO:0030575 | nuclear body organization(GO:0030575) |
2.0 | 51.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
2.0 | 4.0 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
2.0 | 39.9 | GO:0034629 | cellular protein complex localization(GO:0034629) |
2.0 | 10.0 | GO:0006903 | vesicle targeting(GO:0006903) |
2.0 | 2.0 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) |
2.0 | 4.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
2.0 | 8.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
2.0 | 7.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
2.0 | 2.0 | GO:0019230 | proprioception(GO:0019230) |
2.0 | 5.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
2.0 | 15.7 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
2.0 | 2.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
2.0 | 5.9 | GO:0015705 | iodide transport(GO:0015705) |
2.0 | 2.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
2.0 | 9.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
2.0 | 3.9 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
1.9 | 7.8 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
1.9 | 1.9 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
1.9 | 11.6 | GO:0060416 | response to growth hormone(GO:0060416) |
1.9 | 7.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.9 | 7.7 | GO:0019068 | virion assembly(GO:0019068) |
1.9 | 9.7 | GO:0015871 | choline transport(GO:0015871) |
1.9 | 9.6 | GO:0051026 | chiasma assembly(GO:0051026) |
1.9 | 9.6 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
1.9 | 5.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.9 | 21.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.9 | 36.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
1.9 | 3.8 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
1.9 | 7.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.9 | 1.9 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.9 | 3.8 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
1.9 | 3.8 | GO:0009249 | protein lipoylation(GO:0009249) |
1.9 | 53.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
1.9 | 3.8 | GO:0043174 | nucleoside salvage(GO:0043174) |
1.9 | 5.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
1.9 | 30.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.9 | 11.3 | GO:0042026 | protein refolding(GO:0042026) |
1.9 | 43.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
1.9 | 9.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
1.9 | 11.2 | GO:0097286 | iron ion import(GO:0097286) |
1.9 | 7.5 | GO:0043987 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
1.9 | 1.9 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.9 | 1.9 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.9 | 3.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.9 | 3.7 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
1.9 | 14.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
1.9 | 7.5 | GO:0048255 | mRNA stabilization(GO:0048255) |
1.9 | 13.0 | GO:0006560 | proline metabolic process(GO:0006560) |
1.9 | 1.9 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) negative regulation of fatty acid oxidation(GO:0046322) |
1.8 | 5.5 | GO:0008228 | opsonization(GO:0008228) |
1.8 | 5.5 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.8 | 3.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.8 | 1.8 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
1.8 | 1.8 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.8 | 7.3 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
1.8 | 1.8 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
1.8 | 7.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.8 | 5.5 | GO:0040031 | snRNA modification(GO:0040031) |
1.8 | 5.5 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
1.8 | 7.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
1.8 | 5.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
1.8 | 7.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.8 | 7.2 | GO:0006401 | RNA catabolic process(GO:0006401) |
1.8 | 18.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
1.8 | 7.2 | GO:0051697 | protein delipidation(GO:0051697) |
1.8 | 1.8 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
1.8 | 1.8 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
1.8 | 50.4 | GO:0031497 | chromatin assembly(GO:0031497) |
1.8 | 5.4 | GO:0044351 | macropinocytosis(GO:0044351) |
1.8 | 1.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.8 | 10.8 | GO:0035608 | protein deglutamylation(GO:0035608) |
1.8 | 14.3 | GO:0031297 | replication fork processing(GO:0031297) |
1.8 | 3.6 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
1.8 | 8.9 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.8 | 1.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.8 | 1.8 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
1.8 | 25.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
1.8 | 5.4 | GO:0080009 | mRNA methylation(GO:0080009) |
1.8 | 3.6 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
1.8 | 5.3 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
1.8 | 10.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
1.8 | 3.6 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
1.8 | 21.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
1.8 | 5.3 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
1.8 | 1.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.8 | 8.9 | GO:0046836 | glycolipid transport(GO:0046836) |
1.8 | 8.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.8 | 5.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.8 | 8.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.8 | 7.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.8 | 19.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.8 | 40.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
1.8 | 10.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.8 | 14.1 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.8 | 8.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.8 | 3.5 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
1.8 | 1.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
1.8 | 5.3 | GO:0060039 | pericardium development(GO:0060039) |
1.8 | 17.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
1.8 | 35.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
1.7 | 1.7 | GO:0006534 | cysteine metabolic process(GO:0006534) |
1.7 | 1.7 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
1.7 | 13.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
1.7 | 5.2 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.7 | 3.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.7 | 5.2 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.7 | 1.7 | GO:0006598 | polyamine catabolic process(GO:0006598) |
1.7 | 5.2 | GO:0007144 | female meiosis I(GO:0007144) |
1.7 | 3.4 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
1.7 | 3.4 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.7 | 8.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.7 | 5.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
1.7 | 3.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.7 | 5.1 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
1.7 | 6.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.7 | 5.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
1.7 | 1.7 | GO:0019042 | viral latency(GO:0019042) |
1.7 | 8.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
1.7 | 3.4 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
1.7 | 30.4 | GO:0030488 | tRNA methylation(GO:0030488) |
1.7 | 20.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
1.7 | 3.4 | GO:0000052 | citrulline metabolic process(GO:0000052) |
1.7 | 1.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
1.7 | 11.8 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
1.7 | 1.7 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.7 | 5.0 | GO:0048478 | replication fork protection(GO:0048478) |
1.7 | 10.1 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
1.7 | 8.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.7 | 25.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.7 | 1.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
1.7 | 13.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
1.7 | 3.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.7 | 1.7 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
1.7 | 6.6 | GO:0016075 | rRNA catabolic process(GO:0016075) |
1.7 | 14.9 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
1.7 | 3.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.7 | 6.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.7 | 1.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
1.7 | 11.6 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
1.6 | 1.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
1.6 | 4.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.6 | 9.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
1.6 | 8.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.6 | 3.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.6 | 4.9 | GO:0048102 | autophagic cell death(GO:0048102) |
1.6 | 13.1 | GO:0007143 | female meiotic division(GO:0007143) |
1.6 | 4.9 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
1.6 | 6.5 | GO:0051031 | tRNA transport(GO:0051031) |
1.6 | 3.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.6 | 11.3 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
1.6 | 4.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.6 | 9.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.6 | 8.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.6 | 6.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
1.6 | 32.0 | GO:0006414 | translational elongation(GO:0006414) |
1.6 | 3.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.6 | 1.6 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
1.6 | 11.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
1.6 | 8.0 | GO:0007097 | nuclear migration(GO:0007097) |
1.6 | 6.4 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
1.6 | 11.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.6 | 1.6 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
1.6 | 1.6 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
1.6 | 22.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
1.6 | 4.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.6 | 1.6 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
1.6 | 11.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.6 | 4.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.6 | 73.1 | GO:0007030 | Golgi organization(GO:0007030) |
1.6 | 7.8 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
1.6 | 6.2 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
1.5 | 7.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.5 | 3.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.5 | 3.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
1.5 | 13.9 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
1.5 | 3.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.5 | 4.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
1.5 | 7.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
1.5 | 1.5 | GO:1905208 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
1.5 | 13.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
1.5 | 7.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.5 | 9.2 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
1.5 | 12.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.5 | 7.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
1.5 | 6.1 | GO:0006116 | NADH oxidation(GO:0006116) |
1.5 | 33.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.5 | 3.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.5 | 3.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.5 | 1.5 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
1.5 | 3.0 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
1.5 | 3.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.5 | 3.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
1.5 | 3.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.5 | 4.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.5 | 21.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
1.5 | 6.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
1.5 | 1.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.5 | 1.5 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
1.5 | 1.5 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.5 | 4.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.5 | 4.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.5 | 27.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
1.5 | 1.5 | GO:0016137 | glycoside metabolic process(GO:0016137) |
1.5 | 12.0 | GO:0016071 | mRNA metabolic process(GO:0016071) |
1.5 | 3.0 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
1.5 | 7.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.5 | 6.0 | GO:0035878 | nail development(GO:0035878) |
1.5 | 1.5 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
1.5 | 7.4 | GO:0009650 | UV protection(GO:0009650) |
1.5 | 1.5 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
1.5 | 1.5 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
1.5 | 1.5 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
1.5 | 3.0 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
1.5 | 1.5 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
1.5 | 5.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.5 | 1.5 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.5 | 8.9 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
1.5 | 3.0 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
1.5 | 4.4 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
1.5 | 1.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.5 | 28.0 | GO:0006284 | base-excision repair(GO:0006284) |
1.5 | 48.7 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
1.5 | 5.9 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
1.5 | 7.4 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.5 | 4.4 | GO:0051304 | chromosome separation(GO:0051304) |
1.5 | 10.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.5 | 1.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
1.5 | 10.2 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
1.5 | 2.9 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
1.5 | 59.9 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
1.5 | 17.5 | GO:0045116 | protein neddylation(GO:0045116) |
1.5 | 1.5 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
1.5 | 4.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.5 | 1.5 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
1.5 | 4.4 | GO:0033762 | response to glucagon(GO:0033762) |
1.5 | 1.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.5 | 4.4 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
1.4 | 1.4 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
1.4 | 2.9 | GO:0010883 | regulation of lipid storage(GO:0010883) |
1.4 | 1.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.4 | 8.7 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
1.4 | 1.4 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
1.4 | 4.3 | GO:0007379 | segment specification(GO:0007379) |
1.4 | 18.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
1.4 | 8.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.4 | 4.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
1.4 | 35.8 | GO:0051028 | mRNA transport(GO:0051028) |
1.4 | 2.9 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
1.4 | 2.9 | GO:0043584 | nose development(GO:0043584) |
1.4 | 4.3 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
1.4 | 25.6 | GO:0006405 | RNA export from nucleus(GO:0006405) |
1.4 | 4.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
1.4 | 11.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.4 | 2.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.4 | 1.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.4 | 1.4 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
1.4 | 2.8 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.4 | 4.2 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
1.4 | 4.2 | GO:0007525 | somatic muscle development(GO:0007525) |
1.4 | 4.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.4 | 2.8 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
1.4 | 1.4 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
1.4 | 4.2 | GO:0060544 | regulation of necroptotic process(GO:0060544) negative regulation of necroptotic process(GO:0060546) |
1.4 | 2.8 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
1.4 | 4.2 | GO:0002076 | osteoblast development(GO:0002076) |
1.4 | 7.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
1.4 | 2.8 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
1.4 | 11.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
1.4 | 5.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.4 | 1.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
1.4 | 4.1 | GO:0015886 | heme transport(GO:0015886) |
1.4 | 6.9 | GO:0019695 | choline metabolic process(GO:0019695) |
1.4 | 6.9 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
1.4 | 6.8 | GO:0016266 | O-glycan processing(GO:0016266) |
1.4 | 9.6 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
1.4 | 1.4 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
1.4 | 4.1 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.4 | 4.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
1.4 | 4.1 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.4 | 9.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.4 | 21.8 | GO:0000154 | rRNA modification(GO:0000154) |
1.4 | 9.5 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
1.4 | 5.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
1.4 | 4.1 | GO:1903232 | melanosome assembly(GO:1903232) |
1.4 | 2.7 | GO:0006868 | glutamine transport(GO:0006868) |
1.4 | 6.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
1.4 | 1.4 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
1.3 | 35.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
1.3 | 5.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
1.3 | 8.1 | GO:0048524 | positive regulation of viral process(GO:0048524) |
1.3 | 10.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
1.3 | 6.7 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
1.3 | 2.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.3 | 6.7 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
1.3 | 2.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.3 | 10.7 | GO:0042730 | fibrinolysis(GO:0042730) |
1.3 | 2.7 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.3 | 6.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
1.3 | 12.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.3 | 4.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.3 | 20.0 | GO:0016180 | snRNA processing(GO:0016180) |
1.3 | 18.6 | GO:0031648 | protein destabilization(GO:0031648) |
1.3 | 1.3 | GO:0015817 | histidine transport(GO:0015817) |
1.3 | 2.7 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.3 | 2.7 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
1.3 | 1.3 | GO:0033058 | directional locomotion(GO:0033058) |
1.3 | 7.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
1.3 | 1.3 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
1.3 | 1.3 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
1.3 | 2.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
1.3 | 5.3 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.3 | 2.6 | GO:0017145 | stem cell division(GO:0017145) |
1.3 | 3.9 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.3 | 3.9 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
1.3 | 10.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
1.3 | 7.8 | GO:0006517 | protein deglycosylation(GO:0006517) |
1.3 | 1.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.3 | 3.9 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.3 | 5.2 | GO:0046218 | tryptophan catabolic process(GO:0006569) amine catabolic process(GO:0009310) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
1.3 | 210.0 | GO:0008380 | RNA splicing(GO:0008380) |
1.3 | 3.9 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
1.3 | 3.9 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
1.3 | 2.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
1.3 | 28.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
1.3 | 2.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.3 | 28.3 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
1.3 | 6.4 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
1.3 | 3.9 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
1.3 | 1.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
1.3 | 5.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.3 | 28.1 | GO:0051225 | spindle assembly(GO:0051225) |
1.3 | 14.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
1.3 | 5.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
1.3 | 2.5 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.3 | 2.5 | GO:0008354 | germ cell migration(GO:0008354) |
1.3 | 2.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.3 | 1.3 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
1.3 | 6.3 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
1.3 | 2.5 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
1.3 | 2.5 | GO:0034969 | histone arginine methylation(GO:0034969) |
1.3 | 6.3 | GO:0071569 | protein ufmylation(GO:0071569) |
1.3 | 1.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.3 | 16.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
1.3 | 7.6 | GO:0018904 | ether metabolic process(GO:0018904) |
1.3 | 15.1 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
1.3 | 3.8 | GO:0015744 | succinate transport(GO:0015744) |
1.3 | 2.5 | GO:0007000 | nucleolus organization(GO:0007000) |
1.3 | 7.6 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
1.3 | 10.1 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
1.3 | 1.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.3 | 13.8 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
1.3 | 10.0 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.3 | 3.8 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
1.3 | 3.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
1.2 | 10.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.2 | 6.2 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
1.2 | 2.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.2 | 3.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.2 | 44.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
1.2 | 2.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.2 | 2.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.2 | 23.5 | GO:0007051 | spindle organization(GO:0007051) |
1.2 | 38.2 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
1.2 | 1.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.2 | 22.1 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
1.2 | 1.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.2 | 3.7 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
1.2 | 7.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
1.2 | 4.9 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
1.2 | 2.4 | GO:0042891 | antibiotic transport(GO:0042891) |
1.2 | 8.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
1.2 | 4.9 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.2 | 11.0 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
1.2 | 4.9 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
1.2 | 1.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.2 | 15.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.2 | 6.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.2 | 4.8 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
1.2 | 1.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.2 | 3.6 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
1.2 | 9.7 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
1.2 | 2.4 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
1.2 | 4.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.2 | 14.4 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
1.2 | 2.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.2 | 2.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
1.2 | 2.4 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
1.2 | 4.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.2 | 3.6 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.2 | 8.4 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
1.2 | 1.2 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
1.2 | 1.2 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
1.2 | 1.2 | GO:0072676 | lymphocyte migration(GO:0072676) |
1.2 | 4.8 | GO:1904970 | brush border assembly(GO:1904970) |
1.2 | 1.2 | GO:0070827 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) chromatin maintenance(GO:0070827) |
1.2 | 1.2 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
1.2 | 3.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.2 | 2.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.2 | 3.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
1.2 | 1.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.2 | 5.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.2 | 4.7 | GO:1903012 | positive regulation of bone development(GO:1903012) |
1.2 | 7.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
1.2 | 2.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.2 | 1.2 | GO:0010165 | response to X-ray(GO:0010165) |
1.2 | 11.7 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.2 | 2.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.2 | 2.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
1.2 | 5.9 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
1.2 | 5.8 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.2 | 8.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.2 | 2.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
1.2 | 3.5 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.2 | 3.5 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
1.2 | 3.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.2 | 3.5 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
1.2 | 2.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.2 | 3.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.2 | 3.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.2 | 3.5 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
1.1 | 1.1 | GO:0015677 | copper ion import(GO:0015677) |
1.1 | 2.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.1 | 1.1 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
1.1 | 2.3 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
1.1 | 5.7 | GO:0060173 | appendage development(GO:0048736) limb development(GO:0060173) |
1.1 | 2.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
1.1 | 4.6 | GO:0016073 | snRNA metabolic process(GO:0016073) |
1.1 | 16.0 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
1.1 | 8.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
1.1 | 9.1 | GO:0016926 | protein desumoylation(GO:0016926) |
1.1 | 9.1 | GO:0044804 | nucleophagy(GO:0044804) |
1.1 | 1.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
1.1 | 1.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
1.1 | 1.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
1.1 | 2.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
1.1 | 4.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.1 | 2.3 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
1.1 | 1.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.1 | 3.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.1 | 4.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.1 | 2.2 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
1.1 | 8.9 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
1.1 | 3.4 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.1 | 4.5 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
1.1 | 12.3 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
1.1 | 2.2 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
1.1 | 1.1 | GO:0016447 | somatic recombination of immunoglobulin gene segments(GO:0016447) |
1.1 | 5.5 | GO:0035108 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
1.1 | 7.8 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
1.1 | 4.4 | GO:0051451 | myoblast migration(GO:0051451) |
1.1 | 1.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.1 | 7.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
1.1 | 1.1 | GO:0006415 | translational termination(GO:0006415) |
1.1 | 6.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.1 | 8.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.1 | 11.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.1 | 1.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
1.1 | 5.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.1 | 1.1 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.1 | 5.4 | GO:0051013 | microtubule severing(GO:0051013) |
1.1 | 6.5 | GO:0015825 | L-serine transport(GO:0015825) |
1.1 | 7.6 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
1.1 | 19.6 | GO:0007569 | cell aging(GO:0007569) |
1.1 | 22.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
1.1 | 4.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.1 | 4.3 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
1.1 | 54.1 | GO:0007059 | chromosome segregation(GO:0007059) |
1.1 | 2.2 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
1.1 | 3.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.1 | 30.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
1.1 | 4.3 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
1.1 | 1.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
1.1 | 2.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.1 | 1.1 | GO:1901421 | regulation of response to alcohol(GO:1901419) positive regulation of response to alcohol(GO:1901421) |
1.1 | 3.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.1 | 4.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.1 | 9.5 | GO:0002467 | germinal center formation(GO:0002467) |
1.1 | 4.2 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
1.1 | 6.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
1.1 | 20.1 | GO:0006413 | translational initiation(GO:0006413) |
1.1 | 23.2 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
1.1 | 4.2 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
1.1 | 14.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
1.1 | 4.2 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
1.0 | 1.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
1.0 | 5.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
1.0 | 28.2 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
1.0 | 8.4 | GO:0048484 | enteric nervous system development(GO:0048484) |
1.0 | 15.7 | GO:0048286 | lung alveolus development(GO:0048286) |
1.0 | 9.3 | GO:0051904 | pigment granule transport(GO:0051904) |
1.0 | 6.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
1.0 | 2.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
1.0 | 6.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
1.0 | 3.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.0 | 1.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
1.0 | 2.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
1.0 | 7.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
1.0 | 4.1 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
1.0 | 4.1 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
1.0 | 1.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.0 | 5.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.0 | 3.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
1.0 | 1.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.0 | 3.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
1.0 | 6.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.0 | 29.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
1.0 | 6.1 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.0 | 11.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
1.0 | 14.2 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
1.0 | 2.0 | GO:0002254 | kinin cascade(GO:0002254) |
1.0 | 1.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
1.0 | 3.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.0 | 6.0 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
1.0 | 2.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
1.0 | 7.0 | GO:0015858 | nucleoside transport(GO:0015858) |
1.0 | 17.0 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
1.0 | 2.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.0 | 6.0 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
1.0 | 8.9 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
1.0 | 6.0 | GO:0060324 | face development(GO:0060324) |
1.0 | 1.0 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
1.0 | 16.8 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
1.0 | 6.9 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
1.0 | 9.8 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
1.0 | 6.9 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
1.0 | 3.9 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
1.0 | 8.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.0 | 59.4 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
1.0 | 1.0 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
1.0 | 1.9 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.0 | 1.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.0 | 2.9 | GO:0019985 | translesion synthesis(GO:0019985) |
1.0 | 2.9 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
1.0 | 1.9 | GO:0051653 | spindle localization(GO:0051653) |
1.0 | 10.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
1.0 | 26.1 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
1.0 | 12.6 | GO:0048144 | fibroblast proliferation(GO:0048144) |
1.0 | 1.0 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) pyrimidine ribonucleotide biosynthetic process(GO:0009220) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
1.0 | 2.9 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.0 | 1.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.0 | 2.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.0 | 1.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
1.0 | 5.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.0 | 1.9 | GO:0040009 | regulation of growth rate(GO:0040009) |
1.0 | 2.9 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
1.0 | 10.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.9 | 0.9 | GO:0051645 | Golgi localization(GO:0051645) |
0.9 | 9.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.9 | 3.8 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.9 | 0.9 | GO:0051182 | coenzyme transport(GO:0051182) |
0.9 | 3.8 | GO:0097491 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.9 | 28.0 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.9 | 3.7 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.9 | 13.0 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.9 | 1.9 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.9 | 1.9 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.9 | 3.7 | GO:0006997 | nucleus organization(GO:0006997) |
0.9 | 1.9 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.9 | 1.9 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.9 | 10.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.9 | 1.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.9 | 1.8 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.9 | 0.9 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.9 | 8.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.9 | 5.5 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.9 | 5.5 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.9 | 6.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.9 | 0.9 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.9 | 13.7 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.9 | 1.8 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.9 | 3.6 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.9 | 4.5 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.9 | 25.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.9 | 6.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.9 | 2.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.9 | 4.5 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.9 | 9.0 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.9 | 42.1 | GO:0006396 | RNA processing(GO:0006396) |
0.9 | 2.7 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.9 | 0.9 | GO:0016559 | peroxisome fission(GO:0016559) |
0.9 | 8.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.9 | 0.9 | GO:0061525 | hindgut development(GO:0061525) |
0.9 | 3.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.9 | 1.8 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.9 | 0.9 | GO:0010421 | hydrogen peroxide-mediated programmed cell death(GO:0010421) programmed cell death in response to reactive oxygen species(GO:0097468) |
0.9 | 0.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.9 | 1.8 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.9 | 2.6 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.9 | 5.3 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.9 | 2.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.9 | 0.9 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
0.9 | 3.5 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.9 | 0.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.9 | 0.9 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.9 | 2.6 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.9 | 4.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.9 | 22.6 | GO:0051168 | nuclear export(GO:0051168) |
0.9 | 2.6 | GO:0033387 | putrescine biosynthetic process(GO:0009446) putrescine biosynthetic process from ornithine(GO:0033387) |
0.9 | 13.0 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.9 | 0.9 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.9 | 32.8 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.9 | 0.9 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.9 | 5.2 | GO:0033044 | regulation of chromosome organization(GO:0033044) |
0.9 | 3.4 | GO:0032095 | regulation of response to food(GO:0032095) |
0.9 | 1.7 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.9 | 1.7 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.9 | 2.6 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.9 | 0.9 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.9 | 0.9 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.9 | 21.3 | GO:0009060 | aerobic respiration(GO:0009060) |
0.8 | 1.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.8 | 1.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.8 | 6.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.8 | 0.8 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.8 | 3.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.8 | 11.7 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.8 | 0.8 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.8 | 3.3 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.8 | 0.8 | GO:0050832 | defense response to fungus(GO:0050832) |
0.8 | 2.5 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.8 | 25.7 | GO:0006397 | mRNA processing(GO:0006397) |
0.8 | 5.0 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.8 | 8.3 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.8 | 9.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.8 | 3.3 | GO:0030539 | male genitalia development(GO:0030539) |
0.8 | 5.8 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.8 | 144.9 | GO:0006412 | translation(GO:0006412) |
0.8 | 1.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.8 | 2.5 | GO:0007127 | meiosis I(GO:0007127) |
0.8 | 4.9 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.8 | 19.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.8 | 1.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.8 | 1.6 | GO:0070268 | cornification(GO:0070268) |
0.8 | 3.3 | GO:0036233 | glycine import(GO:0036233) |
0.8 | 3.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.8 | 0.8 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.8 | 1.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.8 | 3.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.8 | 0.8 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.8 | 6.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.8 | 5.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.8 | 1.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.8 | 1.6 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.8 | 5.6 | GO:0018205 | peptidyl-lysine modification(GO:0018205) |
0.8 | 2.4 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.8 | 4.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.8 | 50.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.8 | 0.8 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.8 | 0.8 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.8 | 18.3 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.8 | 0.8 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.8 | 2.4 | GO:0070266 | necroptotic process(GO:0070266) |
0.8 | 7.1 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.8 | 15.8 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.8 | 3.2 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.8 | 2.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.8 | 2.4 | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090100) |
0.8 | 2.3 | GO:0098868 | bone growth(GO:0098868) |
0.8 | 1.6 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.8 | 2.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.8 | 1.6 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.8 | 0.8 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.8 | 1.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.8 | 7.0 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.8 | 2.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.8 | 0.8 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.8 | 3.1 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.8 | 2.3 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.8 | 0.8 | GO:0032196 | transposition(GO:0032196) |
0.8 | 1.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.8 | 0.8 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.8 | 0.8 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.8 | 2.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.8 | 0.8 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.8 | 3.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.7 | 4.5 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.7 | 2.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.7 | 2.2 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.7 | 0.7 | GO:0006301 | postreplication repair(GO:0006301) |
0.7 | 6.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.7 | 3.0 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.7 | 3.7 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.7 | 0.7 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.7 | 1.5 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.7 | 1.5 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.7 | 0.7 | GO:0052248 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
0.7 | 10.3 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.7 | 1.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.7 | 1.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.7 | 1.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.7 | 2.9 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.7 | 5.8 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.7 | 77.7 | GO:0006325 | chromatin organization(GO:0006325) |
0.7 | 0.7 | GO:2000407 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.7 | 1.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.7 | 0.7 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.7 | 0.7 | GO:0098534 | centriole assembly(GO:0098534) |
0.7 | 0.7 | GO:0032329 | serine transport(GO:0032329) |
0.7 | 0.7 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.7 | 0.7 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.7 | 3.5 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.7 | 1.4 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.7 | 8.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.7 | 5.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.7 | 3.5 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.7 | 0.7 | GO:2000779 | regulation of double-strand break repair(GO:2000779) |
0.7 | 2.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.7 | 1.4 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.7 | 9.7 | GO:0001889 | liver development(GO:0001889) |
0.7 | 0.7 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.7 | 3.4 | GO:0006548 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.7 | 2.1 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.7 | 4.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.7 | 8.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.7 | 25.0 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.7 | 16.9 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.7 | 5.4 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.7 | 3.3 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.7 | 1.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.7 | 1.3 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.7 | 2.6 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.7 | 0.7 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.7 | 2.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.7 | 6.6 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.7 | 1.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.7 | 3.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.6 | 1.3 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.6 | 5.8 | GO:0030033 | microvillus assembly(GO:0030033) |
0.6 | 0.6 | GO:0030878 | thyroid gland development(GO:0030878) |
0.6 | 5.1 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.6 | 1.9 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.6 | 2.5 | GO:0002507 | tolerance induction(GO:0002507) |
0.6 | 1.9 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.6 | 20.1 | GO:0072376 | protein activation cascade(GO:0072376) |
0.6 | 1.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.6 | 1.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.6 | 22.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.6 | 1.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.6 | 0.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.6 | 3.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.6 | 1.2 | GO:0019076 | viral release from host cell(GO:0019076) |
0.6 | 0.6 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.6 | 3.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.6 | 4.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.6 | 7.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.6 | 4.9 | GO:0048599 | oocyte development(GO:0048599) |
0.6 | 1.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.6 | 28.3 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.6 | 0.6 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.6 | 0.6 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.6 | 1.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.6 | 2.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.6 | 13.1 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.6 | 1.8 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.6 | 0.6 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.6 | 1.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.6 | 8.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.6 | 2.9 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.6 | 1.8 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.6 | 1.8 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 1.8 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.6 | 1.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.6 | 2.9 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.6 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.6 | 0.6 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.6 | 2.3 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.6 | 0.6 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.6 | 2.3 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.6 | 6.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.6 | 1.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.6 | 0.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.6 | 0.6 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.6 | 5.6 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.6 | 0.6 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.6 | 0.6 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.6 | 1.7 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.6 | 3.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.6 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.6 | 3.9 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.6 | 0.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.6 | 5.0 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.5 | 2.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 0.5 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.5 | 0.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.5 | 1.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.5 | 2.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.5 | 3.3 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.5 | 1.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 33.5 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.5 | 3.2 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.5 | 2.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.5 | 5.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 1.1 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.5 | 1.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.5 | 1.1 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.5 | 2.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.5 | 3.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.5 | 1.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.5 | 1.6 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.5 | 0.5 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.5 | 2.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.5 | 2.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.5 | 1.5 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.5 | 0.5 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.5 | 0.5 | GO:0042921 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.5 | 1.5 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.5 | 5.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.5 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 1.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.5 | 0.5 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.5 | 3.0 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.5 | 0.5 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.5 | 3.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.5 | 2.0 | GO:1903727 | positive regulation of phospholipid metabolic process(GO:1903727) |
0.5 | 1.0 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
0.5 | 3.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.5 | 4.9 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.5 | 1.5 | GO:0072091 | regulation of stem cell proliferation(GO:0072091) |
0.5 | 3.4 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.5 | 0.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.5 | 6.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.5 | 7.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.5 | 0.9 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.5 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 0.9 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.5 | 0.5 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.5 | 1.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.5 | 7.9 | GO:0006457 | protein folding(GO:0006457) |
0.5 | 4.6 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.5 | 0.9 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.5 | 1.4 | GO:0002504 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.4 | 0.9 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.4 | 1.8 | GO:0032438 | melanosome organization(GO:0032438) |
0.4 | 0.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.4 | 3.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.4 | 2.6 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.4 | 1.7 | GO:0000723 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.4 | 3.0 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.4 | 3.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.4 | 1.3 | GO:0009642 | response to light intensity(GO:0009642) |
0.4 | 1.3 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.4 | 2.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.4 | 0.9 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.4 | 1.7 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.4 | 0.8 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.4 | 0.8 | GO:0002215 | defense response to nematode(GO:0002215) |
0.4 | 2.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.4 | 1.7 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.4 | 1.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.4 | 1.7 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.4 | 0.4 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.4 | 0.8 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.4 | 1.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 2.5 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) cristae formation(GO:0042407) |
0.4 | 1.6 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.4 | 14.5 | GO:0006281 | DNA repair(GO:0006281) |
0.4 | 1.2 | GO:1903900 | regulation of viral life cycle(GO:1903900) |
0.4 | 1.2 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.4 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 0.4 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.4 | 0.8 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.4 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 1.9 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.4 | 4.2 | GO:1901998 | toxin transport(GO:1901998) |
0.4 | 4.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 0.4 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.4 | 1.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 4.1 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.4 | 0.4 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.4 | 3.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.4 | 0.4 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.4 | 0.4 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.4 | 0.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.4 | 0.4 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.4 | 2.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.4 | 1.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.4 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 0.7 | GO:0006304 | DNA modification(GO:0006304) |
0.4 | 0.4 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.4 | 1.8 | GO:0043632 | modification-dependent macromolecule catabolic process(GO:0043632) |
0.4 | 1.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.4 | 1.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 1.4 | GO:0015893 | drug transport(GO:0015893) |
0.4 | 1.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 0.7 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.4 | 0.4 | GO:0071725 | response to bacterial lipoprotein(GO:0032493) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.4 | 3.9 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.4 | 2.1 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.3 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 0.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 1.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.3 | 1.7 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.3 | 0.3 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.3 | 2.4 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.3 | 0.3 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.3 | 4.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.3 | 1.7 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.3 | 0.3 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.3 | 0.7 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 1.7 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.3 | 1.0 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 0.3 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.3 | 4.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.3 | 2.6 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.3 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 0.3 | GO:0060579 | ventral spinal cord interneuron differentiation(GO:0021514) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.3 | 3.5 | GO:0042073 | intraciliary transport(GO:0042073) |
0.3 | 0.6 | GO:0042991 | transcription factor import into nucleus(GO:0042991) |
0.3 | 0.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 2.8 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.3 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 0.3 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.3 | 1.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 10.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.3 | 4.4 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
0.3 | 0.6 | GO:0001945 | lymph vessel development(GO:0001945) |
0.3 | 0.6 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.3 | 1.7 | GO:0051276 | chromosome organization(GO:0051276) |
0.3 | 0.3 | GO:0055098 | response to lipoprotein particle(GO:0055094) response to low-density lipoprotein particle(GO:0055098) |
0.3 | 0.3 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.3 | 0.6 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.3 | 1.1 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.3 | 1.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.3 | 2.7 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.3 | 1.1 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.3 | 0.3 | GO:0046271 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.3 | 1.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.3 | 3.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.3 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.3 | 0.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 1.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 0.8 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 1.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 4.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.3 | 0.3 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.3 | 1.0 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.3 | 9.3 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.3 | 2.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 0.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 1.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.2 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 1.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 0.5 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.2 | 0.7 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.7 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.2 | 2.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.5 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.2 | 0.2 | GO:0002821 | positive regulation of adaptive immune response(GO:0002821) |
0.2 | 0.2 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.2 | 0.2 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.2 | 1.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.7 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.2 | 1.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 9.8 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.2 | 0.2 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.2 | 3.2 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 2.0 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.2 | 0.7 | GO:0036314 | response to sterol(GO:0036314) |
0.2 | 1.6 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 0.7 | GO:0070265 | necrotic cell death(GO:0070265) |
0.2 | 0.2 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.2 | 0.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 0.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.6 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.2 | 1.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.4 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 2.5 | GO:0010608 | posttranscriptional regulation of gene expression(GO:0010608) |
0.2 | 0.2 | GO:1903580 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.2 | 1.2 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.2 | 0.4 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 0.4 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.2 | 0.8 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 0.4 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.2 | 216.3 | GO:0006351 | transcription, DNA-templated(GO:0006351) |
0.2 | 0.4 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.2 | 1.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.2 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.2 | 0.2 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 1.7 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 0.8 | GO:0045637 | regulation of myeloid cell differentiation(GO:0045637) |
0.2 | 0.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 1.5 | GO:0043473 | pigmentation(GO:0043473) |
0.2 | 1.9 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.2 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.2 | 0.6 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.2 | 0.2 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.2 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.5 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.2 | 0.2 | GO:0048806 | genitalia development(GO:0048806) |
0.2 | 0.4 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.2 | 0.2 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.2 | 0.2 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.2 | 0.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.5 | GO:0097502 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.2 | 0.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 0.5 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.2 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 1.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.3 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.2 | 0.2 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 9.6 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 0.6 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.4 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.1 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.1 | 0.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.4 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.6 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.7 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.1 | 0.5 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.3 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.7 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.1 | 0.1 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.1 | 0.6 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.2 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.6 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 2.4 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 0.5 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 1.7 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.3 | GO:0030260 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.1 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.7 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.1 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.1 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.2 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.3 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.1 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.1 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.0 | 0.0 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.4 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.2 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 0.3 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.0 | 0.0 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.0 | 0.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.1 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.0 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.0 | 3.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0051297 | centrosome organization(GO:0051297) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.2 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.1 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.0 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.0 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.0 | 1.4 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 0.2 | GO:0019835 | cytolysis(GO:0019835) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.7 | 26.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
8.3 | 49.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
8.2 | 41.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
8.1 | 8.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
7.7 | 30.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
6.5 | 26.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
6.3 | 38.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
6.1 | 18.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
6.0 | 18.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
5.9 | 23.5 | GO:0005642 | annulate lamellae(GO:0005642) |
5.5 | 44.1 | GO:0001650 | fibrillar center(GO:0001650) |
5.5 | 21.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
5.4 | 16.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
5.3 | 16.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
5.2 | 26.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
5.2 | 20.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
5.0 | 10.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
4.9 | 24.5 | GO:0005638 | lamin filament(GO:0005638) |
4.9 | 14.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
4.8 | 33.5 | GO:0031931 | TORC1 complex(GO:0031931) |
4.5 | 36.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
4.4 | 326.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
4.4 | 13.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
4.4 | 43.9 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
4.3 | 17.2 | GO:0097452 | GAIT complex(GO:0097452) |
4.3 | 4.3 | GO:0005652 | nuclear lamina(GO:0005652) |
4.2 | 12.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
4.1 | 16.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
4.1 | 8.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
4.1 | 32.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
4.0 | 16.2 | GO:0072487 | MSL complex(GO:0072487) |
4.0 | 28.2 | GO:0042382 | paraspeckles(GO:0042382) |
3.9 | 11.7 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
3.8 | 11.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
3.8 | 18.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
3.8 | 3.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
3.7 | 11.2 | GO:0070552 | BRISC complex(GO:0070552) |
3.7 | 11.1 | GO:0031417 | NatC complex(GO:0031417) |
3.7 | 18.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
3.7 | 102.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
3.6 | 10.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
3.6 | 10.8 | GO:0031523 | Myb complex(GO:0031523) |
3.6 | 17.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
3.6 | 28.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
3.5 | 10.6 | GO:0005955 | calcineurin complex(GO:0005955) |
3.5 | 70.8 | GO:0090544 | BAF-type complex(GO:0090544) |
3.5 | 10.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
3.5 | 28.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
3.5 | 101.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
3.5 | 24.5 | GO:0005688 | U6 snRNP(GO:0005688) |
3.5 | 17.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
3.5 | 6.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
3.3 | 36.3 | GO:0035102 | PRC1 complex(GO:0035102) |
3.3 | 39.5 | GO:0001741 | XY body(GO:0001741) |
3.3 | 19.7 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
3.3 | 29.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
3.3 | 13.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
3.3 | 13.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
3.2 | 74.0 | GO:0031519 | PcG protein complex(GO:0031519) |
3.2 | 44.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
3.2 | 12.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
3.1 | 18.4 | GO:0005796 | Golgi lumen(GO:0005796) |
3.0 | 27.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
3.0 | 9.0 | GO:0097427 | microtubule bundle(GO:0097427) |
3.0 | 20.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
2.9 | 85.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
2.9 | 2.9 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
2.9 | 8.8 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.9 | 23.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
2.9 | 8.7 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.9 | 8.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.9 | 5.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
2.9 | 8.6 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
2.8 | 22.7 | GO:0001939 | female pronucleus(GO:0001939) |
2.8 | 14.1 | GO:0097422 | tubular endosome(GO:0097422) |
2.8 | 14.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
2.8 | 11.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
2.8 | 30.9 | GO:0042555 | MCM complex(GO:0042555) |
2.8 | 16.9 | GO:0031415 | NatA complex(GO:0031415) |
2.8 | 25.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
2.8 | 19.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
2.8 | 8.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
2.8 | 11.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
2.8 | 27.8 | GO:0045120 | pronucleus(GO:0045120) |
2.8 | 52.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
2.8 | 11.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
2.8 | 2.8 | GO:0042575 | DNA polymerase complex(GO:0042575) |
2.7 | 35.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
2.7 | 5.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
2.7 | 16.2 | GO:0070938 | contractile ring(GO:0070938) |
2.7 | 5.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
2.7 | 10.8 | GO:0000938 | GARP complex(GO:0000938) |
2.7 | 2.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
2.7 | 8.0 | GO:0000811 | GINS complex(GO:0000811) |
2.7 | 109.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
2.6 | 23.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
2.6 | 18.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.6 | 2.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
2.6 | 5.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
2.6 | 7.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
2.6 | 15.4 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
2.6 | 7.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
2.5 | 2.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
2.5 | 12.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.5 | 2.5 | GO:0097450 | astrocyte end-foot(GO:0097450) |
2.5 | 10.0 | GO:0071797 | LUBAC complex(GO:0071797) |
2.5 | 10.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
2.5 | 9.9 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
2.5 | 19.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.5 | 17.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
2.5 | 9.8 | GO:1990130 | Iml1 complex(GO:1990130) |
2.5 | 22.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.4 | 29.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
2.4 | 9.7 | GO:1990246 | uniplex complex(GO:1990246) |
2.4 | 4.8 | GO:0072687 | meiotic spindle(GO:0072687) |
2.4 | 7.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.4 | 16.8 | GO:0016600 | flotillin complex(GO:0016600) |
2.4 | 26.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
2.4 | 11.9 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
2.4 | 4.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
2.4 | 7.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
2.3 | 2.3 | GO:0061574 | ASAP complex(GO:0061574) |
2.3 | 7.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
2.3 | 6.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
2.3 | 133.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
2.3 | 9.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
2.3 | 34.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.3 | 49.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
2.3 | 18.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
2.3 | 45.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
2.2 | 78.6 | GO:0005844 | polysome(GO:0005844) |
2.2 | 9.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
2.2 | 15.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
2.2 | 2.2 | GO:0055087 | Ski complex(GO:0055087) |
2.2 | 6.6 | GO:1990423 | RZZ complex(GO:1990423) |
2.2 | 8.9 | GO:0090543 | Flemming body(GO:0090543) |
2.2 | 22.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
2.2 | 4.4 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
2.2 | 11.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
2.2 | 17.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
2.2 | 21.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
2.2 | 6.5 | GO:0097413 | Lewy body(GO:0097413) |
2.2 | 10.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
2.2 | 15.1 | GO:0010369 | chromocenter(GO:0010369) |
2.2 | 2.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
2.1 | 115.9 | GO:0016605 | PML body(GO:0016605) |
2.1 | 6.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.1 | 8.6 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
2.1 | 6.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
2.1 | 6.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
2.1 | 8.3 | GO:0030689 | Noc complex(GO:0030689) |
2.1 | 70.5 | GO:0005876 | spindle microtubule(GO:0005876) |
2.1 | 4.1 | GO:0034709 | methylosome(GO:0034709) |
2.1 | 12.4 | GO:0000812 | Swr1 complex(GO:0000812) |
2.1 | 4.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.0 | 8.2 | GO:0000796 | condensin complex(GO:0000796) |
2.0 | 40.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
2.0 | 2.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
2.0 | 38.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
2.0 | 405.1 | GO:0000785 | chromatin(GO:0000785) |
2.0 | 18.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
2.0 | 17.9 | GO:0030914 | STAGA complex(GO:0030914) |
2.0 | 15.9 | GO:0097542 | ciliary tip(GO:0097542) |
2.0 | 4.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
2.0 | 11.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
2.0 | 15.8 | GO:0031209 | SCAR complex(GO:0031209) |
2.0 | 15.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
2.0 | 2.0 | GO:0098576 | lumenal side of membrane(GO:0098576) |
2.0 | 15.7 | GO:0000124 | SAGA complex(GO:0000124) |
1.9 | 15.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.9 | 3.9 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
1.9 | 89.4 | GO:0005643 | nuclear pore(GO:0005643) |
1.9 | 52.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.9 | 1.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.9 | 3.9 | GO:0071437 | invadopodium(GO:0071437) |
1.9 | 5.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.9 | 5.8 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.9 | 65.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
1.9 | 17.3 | GO:0030904 | retromer complex(GO:0030904) |
1.9 | 7.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.9 | 20.6 | GO:0044453 | nuclear membrane part(GO:0044453) |
1.9 | 11.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.9 | 20.5 | GO:0032039 | integrator complex(GO:0032039) |
1.9 | 7.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.8 | 5.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.8 | 9.2 | GO:0005687 | U4 snRNP(GO:0005687) |
1.8 | 9.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
1.8 | 189.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
1.8 | 20.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.8 | 7.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
1.8 | 7.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.8 | 20.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
1.8 | 12.7 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.8 | 188.5 | GO:0016604 | nuclear body(GO:0016604) |
1.8 | 7.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.8 | 14.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.8 | 16.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.8 | 1.8 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
1.8 | 12.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.8 | 1.8 | GO:0071817 | MMXD complex(GO:0071817) |
1.8 | 8.9 | GO:0035861 | site of double-strand break(GO:0035861) |
1.8 | 5.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
1.8 | 3.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.8 | 10.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.8 | 32.0 | GO:0051233 | spindle midzone(GO:0051233) |
1.8 | 19.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.8 | 19.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
1.8 | 1.8 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
1.7 | 1.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.7 | 8.6 | GO:0044194 | cytolytic granule(GO:0044194) |
1.7 | 370.5 | GO:0005667 | transcription factor complex(GO:0005667) |
1.7 | 6.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.7 | 11.9 | GO:0070652 | HAUS complex(GO:0070652) |
1.7 | 33.8 | GO:0034451 | centriolar satellite(GO:0034451) |
1.7 | 6.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
1.7 | 8.4 | GO:0097342 | ripoptosome(GO:0097342) |
1.7 | 1.7 | GO:0030056 | hemidesmosome(GO:0030056) |
1.7 | 5.0 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.7 | 14.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.7 | 5.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.7 | 3.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.6 | 19.8 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
1.6 | 6.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
1.6 | 27.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.6 | 14.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.6 | 6.5 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
1.6 | 1733.0 | GO:0005654 | nucleoplasm(GO:0005654) |
1.6 | 3.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.6 | 3.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.6 | 6.5 | GO:0035339 | SPOTS complex(GO:0035339) |
1.6 | 11.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
1.6 | 4.8 | GO:0005745 | m-AAA complex(GO:0005745) |
1.6 | 3.2 | GO:0000803 | sex chromosome(GO:0000803) |
1.6 | 45.9 | GO:0008305 | integrin complex(GO:0008305) |
1.6 | 7.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
1.6 | 6.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.6 | 17.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.5 | 4.6 | GO:0005795 | Golgi stack(GO:0005795) |
1.5 | 23.0 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
1.5 | 1.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.5 | 4.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.5 | 10.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.5 | 6.1 | GO:0070820 | tertiary granule(GO:0070820) |
1.5 | 1.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.5 | 66.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.5 | 143.9 | GO:0031965 | nuclear membrane(GO:0031965) |
1.5 | 4.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.5 | 7.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.5 | 76.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
1.5 | 32.1 | GO:0097228 | sperm principal piece(GO:0097228) |
1.5 | 40.8 | GO:0000502 | proteasome complex(GO:0000502) |
1.4 | 5.8 | GO:0035859 | Seh1-associated complex(GO:0035859) |
1.4 | 2.9 | GO:0034708 | methyltransferase complex(GO:0034708) |
1.4 | 1.4 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
1.4 | 8.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.4 | 5.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.4 | 4.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.4 | 159.7 | GO:0005694 | chromosome(GO:0005694) |
1.4 | 45.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.4 | 14.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.4 | 5.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.4 | 2.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.4 | 16.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
1.4 | 4.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.4 | 8.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.4 | 1.4 | GO:0097255 | R2TP complex(GO:0097255) |
1.4 | 1.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.4 | 4.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.3 | 10.8 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
1.3 | 54.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
1.3 | 55.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.3 | 5.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.3 | 5.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.3 | 9.3 | GO:0030008 | TRAPP complex(GO:0030008) |
1.3 | 4.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.3 | 2.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.3 | 4.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.3 | 27.4 | GO:0000922 | spindle pole(GO:0000922) |
1.3 | 2.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.3 | 7.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
1.3 | 21.9 | GO:0002102 | podosome(GO:0002102) |
1.3 | 87.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
1.3 | 7.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.3 | 362.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
1.3 | 1.3 | GO:0071942 | XPC complex(GO:0071942) |
1.3 | 1.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.3 | 7.6 | GO:0031512 | motile primary cilium(GO:0031512) |
1.2 | 16.2 | GO:0016363 | nuclear matrix(GO:0016363) |
1.2 | 1.2 | GO:0000346 | transcription export complex(GO:0000346) |
1.2 | 13.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
1.2 | 8.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.2 | 93.9 | GO:0072562 | blood microparticle(GO:0072562) |
1.2 | 2.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
1.2 | 13.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.2 | 2.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.2 | 7.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.2 | 2.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.2 | 120.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.2 | 17.3 | GO:0000145 | exocyst(GO:0000145) |
1.1 | 4.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
1.1 | 5.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.1 | 2.3 | GO:0098536 | deuterosome(GO:0098536) |
1.1 | 2.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.1 | 15.9 | GO:0030686 | 90S preribosome(GO:0030686) |
1.1 | 5.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.1 | 20.2 | GO:0001772 | immunological synapse(GO:0001772) |
1.1 | 38.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
1.1 | 5.6 | GO:0042587 | glycogen granule(GO:0042587) |
1.1 | 8.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.1 | 12.1 | GO:0001891 | phagocytic cup(GO:0001891) |
1.1 | 1.1 | GO:0071203 | WASH complex(GO:0071203) |
1.1 | 5.4 | GO:0042581 | specific granule(GO:0042581) |
1.1 | 5.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
1.1 | 2.2 | GO:0033263 | CORVET complex(GO:0033263) |
1.1 | 11.8 | GO:0032426 | stereocilium tip(GO:0032426) |
1.1 | 1.1 | GO:0042827 | platelet dense granule(GO:0042827) |
1.1 | 9.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
1.1 | 18.0 | GO:0005776 | autophagosome(GO:0005776) |
1.1 | 7.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.1 | 10.6 | GO:0031528 | microvillus membrane(GO:0031528) |
1.1 | 5.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.0 | 4.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.0 | 6.2 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
1.0 | 1.0 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
1.0 | 12.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.0 | 5.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
1.0 | 258.2 | GO:0005730 | nucleolus(GO:0005730) |
1.0 | 12.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.0 | 11.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.0 | 3.0 | GO:1990391 | DNA repair complex(GO:1990391) |
1.0 | 6.0 | GO:0071986 | Ragulator complex(GO:0071986) |
1.0 | 1.0 | GO:0005686 | U2 snRNP(GO:0005686) |
1.0 | 39.9 | GO:0005811 | lipid particle(GO:0005811) |
1.0 | 18.9 | GO:0031970 | organelle envelope lumen(GO:0031970) |
1.0 | 10.0 | GO:0016234 | inclusion body(GO:0016234) |
1.0 | 1.0 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
1.0 | 3.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
1.0 | 38.6 | GO:0005814 | centriole(GO:0005814) |
1.0 | 2.9 | GO:0030478 | actin cap(GO:0030478) |
1.0 | 1.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
1.0 | 1.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.9 | 0.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.9 | 0.9 | GO:0030891 | VCB complex(GO:0030891) |
0.9 | 5.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.9 | 1.9 | GO:1990923 | PET complex(GO:1990923) |
0.9 | 64.4 | GO:0001726 | ruffle(GO:0001726) |
0.9 | 2.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.9 | 1.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.9 | 1.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.9 | 2.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.9 | 28.0 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.9 | 4.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.9 | 6.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.9 | 1.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.9 | 4.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.9 | 1.7 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.9 | 0.9 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.8 | 5.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.8 | 3.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.8 | 69.1 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.8 | 1989.4 | GO:0005634 | nucleus(GO:0005634) |
0.8 | 6.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.8 | 0.8 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.8 | 1.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.8 | 0.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.8 | 9.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.7 | 3.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.7 | 0.7 | GO:0016939 | kinesin II complex(GO:0016939) |
0.7 | 0.7 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.7 | 5.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.7 | 405.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.7 | 5.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.7 | 5.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.7 | 0.7 | GO:0035838 | growing cell tip(GO:0035838) |
0.7 | 7.1 | GO:0036126 | sperm flagellum(GO:0036126) |
0.7 | 6.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.7 | 1.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.7 | 4.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.7 | 1.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.7 | 1.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.7 | 7.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.6 | 5.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.6 | 87.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.6 | 3.8 | GO:0097470 | ribbon synapse(GO:0097470) |
0.6 | 2.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.6 | 10.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.6 | 1.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.6 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.6 | 4.4 | GO:0030496 | midbody(GO:0030496) |
0.5 | 1.6 | GO:0034464 | BBSome(GO:0034464) |
0.5 | 6.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.5 | 11.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.5 | 4.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.5 | 1.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.5 | 7.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 10.9 | GO:0045177 | apical part of cell(GO:0045177) |
0.5 | 0.5 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.5 | 196.8 | GO:0005829 | cytosol(GO:0005829) |
0.5 | 20.1 | GO:0097223 | sperm part(GO:0097223) |
0.5 | 2.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.5 | 2.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 0.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.5 | 1.5 | GO:0043203 | axon hillock(GO:0043203) |
0.5 | 3.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.5 | 1.9 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.5 | 1.0 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.5 | 1.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.5 | 1.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.4 | 5.2 | GO:0031514 | motile cilium(GO:0031514) |
0.4 | 7.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 4.9 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 0.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 0.4 | GO:0044393 | microspike(GO:0044393) |
0.4 | 1.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 9.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 3.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 0.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 5.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.3 | 2.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 5.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 0.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 3.1 | GO:0030135 | coated vesicle(GO:0030135) |
0.3 | 8.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.3 | 0.3 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 0.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 0.6 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 16.6 | GO:1990234 | transferase complex(GO:1990234) |
0.3 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 17.2 | GO:0005813 | centrosome(GO:0005813) |
0.3 | 1.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 3.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 23.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 3.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 1.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 28.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 204.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 26.2 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.2 | 19.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 1.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 2.4 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 0.4 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.2 | 6.4 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.2 | 9.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 75.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 30.3 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
9.5 | 28.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
7.6 | 30.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
7.4 | 29.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
7.3 | 36.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
6.9 | 41.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
6.7 | 26.9 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
6.2 | 18.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
6.0 | 29.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
5.8 | 5.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
5.8 | 29.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
5.8 | 23.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
5.4 | 21.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
5.3 | 5.3 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
5.3 | 5.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
5.2 | 15.7 | GO:0050692 | DBD domain binding(GO:0050692) |
5.2 | 41.4 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
5.2 | 15.5 | GO:0000339 | RNA cap binding(GO:0000339) |
5.1 | 35.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
5.0 | 64.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
5.0 | 14.9 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
5.0 | 44.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
4.9 | 19.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
4.9 | 14.7 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
4.9 | 24.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
4.9 | 19.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
4.8 | 19.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
4.8 | 14.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
4.8 | 9.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
4.8 | 23.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
4.6 | 18.6 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
4.6 | 4.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
4.6 | 32.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
4.6 | 13.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
4.4 | 252.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
4.4 | 13.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
4.4 | 13.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
4.3 | 17.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
4.3 | 12.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
4.2 | 16.9 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
4.2 | 38.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
4.1 | 24.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
4.1 | 12.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
4.0 | 8.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
4.0 | 16.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
4.0 | 24.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
4.0 | 15.9 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
4.0 | 51.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
4.0 | 4.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
4.0 | 11.9 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
4.0 | 15.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
4.0 | 7.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
4.0 | 4.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
3.9 | 11.7 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
3.9 | 7.8 | GO:1990188 | euchromatin binding(GO:1990188) |
3.9 | 15.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
3.9 | 7.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
3.8 | 30.7 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
3.8 | 26.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
3.8 | 11.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.8 | 7.6 | GO:0032564 | dATP binding(GO:0032564) |
3.8 | 15.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
3.8 | 22.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
3.8 | 11.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
3.8 | 15.0 | GO:0005534 | galactose binding(GO:0005534) |
3.7 | 3.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
3.7 | 18.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
3.7 | 11.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
3.7 | 14.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
3.7 | 18.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
3.7 | 14.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
3.6 | 10.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
3.6 | 10.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
3.6 | 32.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
3.5 | 14.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
3.5 | 31.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
3.5 | 7.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
3.5 | 3.5 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
3.5 | 97.3 | GO:0031491 | nucleosome binding(GO:0031491) |
3.5 | 13.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
3.5 | 10.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
3.4 | 24.0 | GO:0048156 | tau protein binding(GO:0048156) |
3.3 | 16.7 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
3.3 | 13.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
3.3 | 49.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
3.3 | 9.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
3.3 | 9.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
3.3 | 9.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
3.3 | 13.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
3.2 | 13.0 | GO:0009374 | biotin binding(GO:0009374) |
3.2 | 19.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
3.2 | 25.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
3.2 | 9.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
3.2 | 102.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
3.2 | 12.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
3.2 | 28.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
3.1 | 3.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
3.1 | 9.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
3.1 | 93.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
3.1 | 18.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
3.1 | 9.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
3.1 | 33.8 | GO:0035198 | miRNA binding(GO:0035198) |
3.1 | 9.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
3.1 | 12.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
3.1 | 9.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
3.1 | 12.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
3.1 | 9.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
3.0 | 24.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
3.0 | 18.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
3.0 | 9.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
3.0 | 9.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
3.0 | 9.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
3.0 | 32.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.9 | 32.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
2.9 | 8.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
2.9 | 8.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
2.9 | 26.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
2.9 | 8.6 | GO:0043559 | insulin binding(GO:0043559) |
2.9 | 22.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
2.9 | 28.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
2.8 | 11.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
2.8 | 28.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
2.8 | 19.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.8 | 19.7 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
2.8 | 16.8 | GO:0008494 | translation activator activity(GO:0008494) |
2.8 | 5.6 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
2.8 | 25.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
2.8 | 8.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
2.8 | 16.7 | GO:0004064 | arylesterase activity(GO:0004064) |
2.8 | 41.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
2.8 | 8.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.8 | 5.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.8 | 13.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
2.7 | 27.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
2.7 | 138.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
2.7 | 8.1 | GO:0003680 | AT DNA binding(GO:0003680) |
2.7 | 24.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
2.7 | 8.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
2.7 | 5.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
2.6 | 44.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
2.6 | 10.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
2.6 | 2.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
2.6 | 10.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
2.6 | 18.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
2.6 | 12.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.6 | 23.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.6 | 36.0 | GO:0030275 | LRR domain binding(GO:0030275) |
2.6 | 7.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
2.6 | 7.7 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
2.6 | 38.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
2.5 | 15.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
2.5 | 7.6 | GO:0005119 | smoothened binding(GO:0005119) |
2.5 | 12.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
2.5 | 2.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
2.5 | 17.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
2.5 | 22.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.5 | 22.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
2.5 | 7.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.5 | 9.8 | GO:0005522 | profilin binding(GO:0005522) |
2.4 | 12.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
2.4 | 56.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
2.4 | 21.9 | GO:0070717 | poly-purine tract binding(GO:0070717) |
2.4 | 2.4 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
2.4 | 7.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.4 | 14.5 | GO:0034046 | poly(G) binding(GO:0034046) |
2.4 | 19.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
2.4 | 45.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
2.4 | 9.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
2.4 | 7.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
2.4 | 12.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
2.4 | 14.4 | GO:0030983 | mismatched DNA binding(GO:0030983) |
2.4 | 11.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
2.4 | 9.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.4 | 11.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.4 | 174.2 | GO:0001047 | core promoter binding(GO:0001047) |
2.3 | 11.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
2.3 | 4.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
2.3 | 11.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
2.3 | 7.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
2.3 | 2.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
2.3 | 14.0 | GO:0050733 | RS domain binding(GO:0050733) |
2.3 | 16.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
2.3 | 4.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
2.3 | 32.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
2.3 | 4.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
2.3 | 9.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
2.3 | 4.6 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
2.3 | 6.9 | GO:0019961 | interferon binding(GO:0019961) |
2.3 | 20.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
2.3 | 31.7 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
2.3 | 24.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
2.2 | 11.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
2.2 | 6.7 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
2.2 | 38.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
2.2 | 8.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.2 | 15.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
2.2 | 29.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
2.2 | 8.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
2.2 | 8.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
2.2 | 46.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
2.2 | 4.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
2.2 | 6.6 | GO:0004359 | glutaminase activity(GO:0004359) |
2.2 | 8.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
2.2 | 8.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.2 | 19.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
2.2 | 19.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.2 | 2.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.2 | 8.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
2.2 | 6.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.2 | 6.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
2.2 | 38.8 | GO:0035326 | enhancer binding(GO:0035326) |
2.2 | 2.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
2.2 | 4.3 | GO:0036033 | mediator complex binding(GO:0036033) |
2.2 | 2.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.1 | 4.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
2.1 | 6.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
2.1 | 6.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
2.1 | 8.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.1 | 10.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
2.1 | 10.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
2.1 | 23.3 | GO:0008266 | poly-pyrimidine tract binding(GO:0008187) poly(U) RNA binding(GO:0008266) |
2.1 | 8.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
2.1 | 10.5 | GO:0070728 | leucine binding(GO:0070728) |
2.1 | 14.7 | GO:1990446 | U1 snRNP binding(GO:1990446) |
2.1 | 54.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
2.1 | 14.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
2.1 | 118.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
2.1 | 12.5 | GO:1990405 | protein antigen binding(GO:1990405) |
2.1 | 4.2 | GO:0048185 | activin binding(GO:0048185) |
2.1 | 2.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
2.1 | 6.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
2.1 | 10.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
2.0 | 63.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
2.0 | 10.1 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
2.0 | 22.3 | GO:0005521 | lamin binding(GO:0005521) |
2.0 | 180.2 | GO:0042393 | histone binding(GO:0042393) |
2.0 | 20.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
2.0 | 10.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
2.0 | 14.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
2.0 | 6.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
2.0 | 10.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
2.0 | 8.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
2.0 | 42.2 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
2.0 | 4.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
2.0 | 2.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
2.0 | 24.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
2.0 | 16.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
2.0 | 58.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
2.0 | 10.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
2.0 | 11.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
2.0 | 17.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
2.0 | 5.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
2.0 | 7.9 | GO:0043515 | kinetochore binding(GO:0043515) |
2.0 | 15.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
2.0 | 2.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
2.0 | 11.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.9 | 7.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
1.9 | 17.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
1.9 | 1.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.9 | 3.9 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
1.9 | 3.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.9 | 9.7 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
1.9 | 25.1 | GO:0043022 | ribosome binding(GO:0043022) |
1.9 | 27.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.9 | 5.8 | GO:0019862 | IgA binding(GO:0019862) |
1.9 | 1.9 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.9 | 3.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.9 | 5.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.9 | 30.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.9 | 1.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
1.9 | 5.7 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.9 | 9.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
1.9 | 7.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.9 | 5.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.9 | 9.4 | GO:0005113 | patched binding(GO:0005113) |
1.9 | 5.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.9 | 22.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.9 | 90.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.9 | 5.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.9 | 3.8 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.9 | 80.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
1.9 | 7.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.9 | 9.3 | GO:0034452 | dynactin binding(GO:0034452) |
1.9 | 5.6 | GO:0030984 | kininogen binding(GO:0030984) |
1.8 | 3.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.8 | 58.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
1.8 | 1.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.8 | 7.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.8 | 9.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.8 | 18.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
1.8 | 18.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.8 | 5.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.8 | 5.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.8 | 32.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.8 | 1.8 | GO:0051425 | PTB domain binding(GO:0051425) |
1.8 | 5.3 | GO:0000182 | rDNA binding(GO:0000182) |
1.8 | 21.3 | GO:0001618 | virus receptor activity(GO:0001618) |
1.8 | 14.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.8 | 1.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.8 | 1.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.8 | 1.8 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
1.8 | 21.2 | GO:0030332 | cyclin binding(GO:0030332) |
1.8 | 17.6 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
1.8 | 7.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.8 | 7.0 | GO:0015232 | heme transporter activity(GO:0015232) |
1.8 | 40.3 | GO:0045502 | dynein binding(GO:0045502) |
1.8 | 1.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.8 | 15.8 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
1.7 | 10.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.7 | 20.9 | GO:0017166 | vinculin binding(GO:0017166) |
1.7 | 1.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.7 | 40.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.7 | 17.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.7 | 5.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.7 | 5.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
1.7 | 31.3 | GO:0034061 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
1.7 | 12.1 | GO:0070628 | proteasome binding(GO:0070628) |
1.7 | 8.6 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
1.7 | 84.1 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
1.7 | 30.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.7 | 258.2 | GO:0003682 | chromatin binding(GO:0003682) |
1.7 | 8.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.7 | 5.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.7 | 28.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
1.7 | 5.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.7 | 10.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.7 | 33.6 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
1.7 | 6.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.7 | 5.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.7 | 3.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.7 | 6.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.7 | 11.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.7 | 8.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.7 | 5.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.7 | 5.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.6 | 6.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.6 | 3.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.6 | 11.5 | GO:0031386 | protein tag(GO:0031386) |
1.6 | 6.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.6 | 14.7 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
1.6 | 9.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.6 | 3.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.6 | 6.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.6 | 159.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
1.6 | 13.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.6 | 4.9 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.6 | 126.6 | GO:0003713 | transcription coactivator activity(GO:0003713) |
1.6 | 6.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.6 | 11.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
1.6 | 4.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.6 | 6.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
1.6 | 21.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
1.6 | 8.1 | GO:0005499 | vitamin D binding(GO:0005499) |
1.6 | 4.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
1.6 | 53.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
1.6 | 6.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.6 | 1.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
1.6 | 12.7 | GO:0031996 | thioesterase binding(GO:0031996) |
1.6 | 6.4 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.6 | 7.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.6 | 1.6 | GO:0004659 | prenyltransferase activity(GO:0004659) |
1.6 | 23.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.6 | 6.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.6 | 195.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
1.6 | 1126.0 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
1.6 | 3.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.6 | 4.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.5 | 7.7 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
1.5 | 1.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.5 | 6.2 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
1.5 | 12.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.5 | 3.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.5 | 6.1 | GO:0005542 | folic acid binding(GO:0005542) |
1.5 | 32.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.5 | 7.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.5 | 24.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.5 | 4.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.5 | 6.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
1.5 | 6.0 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
1.5 | 6.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.5 | 19.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.5 | 4.5 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
1.5 | 6.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
1.5 | 3.0 | GO:0031014 | troponin T binding(GO:0031014) |
1.5 | 17.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
1.5 | 11.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.5 | 7.4 | GO:0008199 | ferric iron binding(GO:0008199) |
1.5 | 8.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.5 | 4.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.5 | 1.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.5 | 4.4 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
1.5 | 5.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.5 | 10.3 | GO:0050700 | CARD domain binding(GO:0050700) |
1.5 | 1.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.5 | 4.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.4 | 1.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.4 | 134.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.4 | 8.6 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.4 | 153.2 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
1.4 | 1.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.4 | 2.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.4 | 5.7 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
1.4 | 4.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.4 | 1.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.4 | 16.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.4 | 8.4 | GO:0015288 | porin activity(GO:0015288) |
1.4 | 5.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.4 | 5.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.4 | 11.1 | GO:0018446 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.4 | 19.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
1.4 | 5.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.3 | 110.5 | GO:0018169 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
1.3 | 6.7 | GO:0017040 | ceramidase activity(GO:0017040) |
1.3 | 4.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.3 | 5.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.3 | 5.4 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
1.3 | 1.3 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
1.3 | 23.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.3 | 17.2 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
1.3 | 9.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.3 | 26.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.3 | 49.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
1.3 | 24.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
1.3 | 1.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.3 | 3.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.3 | 2.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.3 | 5.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.3 | 6.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.3 | 5.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.3 | 10.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.3 | 16.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
1.3 | 3.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.3 | 27.9 | GO:0030145 | manganese ion binding(GO:0030145) |
1.3 | 5.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.3 | 19.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.3 | 135.5 | GO:0001067 | regulatory region DNA binding(GO:0000975) regulatory region nucleic acid binding(GO:0001067) |
1.3 | 3.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.2 | 2.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.2 | 5.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.2 | 2.5 | GO:0019002 | GMP binding(GO:0019002) |
1.2 | 3.7 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.2 | 18.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.2 | 2.4 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.2 | 1.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
1.2 | 2.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.2 | 4.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.2 | 3.7 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.2 | 1.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.2 | 24.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.2 | 7.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.2 | 3.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.2 | 30.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
1.2 | 722.8 | GO:0003677 | DNA binding(GO:0003677) |
1.2 | 3.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.2 | 3.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.2 | 21.3 | GO:0016504 | peptidase activator activity(GO:0016504) |
1.2 | 4.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.2 | 2.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.2 | 14.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.2 | 49.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
1.2 | 7.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.2 | 7.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.2 | 3.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.1 | 2.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
1.1 | 2.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.1 | 3.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.1 | 3.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.1 | 9.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.1 | 4.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.1 | 20.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
1.1 | 7.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.1 | 15.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
1.1 | 1.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.1 | 5.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.1 | 4.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.1 | 62.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.1 | 10.9 | GO:0004527 | exonuclease activity(GO:0004527) |
1.1 | 2.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.1 | 5.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.1 | 6.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.1 | 1.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
1.1 | 8.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.1 | 1.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.1 | 3.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.1 | 3.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.1 | 2.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.1 | 4.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.0 | 19.9 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
1.0 | 3.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.0 | 9.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.0 | 5.2 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.0 | 2.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.0 | 22.6 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
1.0 | 11.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.0 | 2.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.0 | 10.2 | GO:0004568 | chitinase activity(GO:0004568) |
1.0 | 35.6 | GO:0051087 | chaperone binding(GO:0051087) |
1.0 | 4.1 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
1.0 | 3.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.0 | 6.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.0 | 4.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.0 | 9.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
1.0 | 9.0 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
1.0 | 9.0 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
1.0 | 2.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.0 | 9.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.0 | 8.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
1.0 | 7.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.0 | 1.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.0 | 4.9 | GO:0048038 | quinone binding(GO:0048038) |
1.0 | 42.4 | GO:0008565 | protein transporter activity(GO:0008565) |
1.0 | 2.9 | GO:0097016 | L27 domain binding(GO:0097016) |
1.0 | 9.7 | GO:0043531 | ADP binding(GO:0043531) |
1.0 | 4.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.0 | 12.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.0 | 3.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.0 | 5.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.0 | 6.8 | GO:0015248 | sterol transporter activity(GO:0015248) |
1.0 | 1.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.0 | 2.9 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.0 | 3.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.9 | 3.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.9 | 2.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.9 | 7.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.9 | 19.7 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.9 | 26.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.9 | 0.9 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.9 | 14.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.9 | 7.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.9 | 3.7 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.9 | 3.7 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.9 | 2.8 | GO:0019213 | deacetylase activity(GO:0019213) |
0.9 | 2.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.9 | 6.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.9 | 32.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.9 | 3.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.9 | 3.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.9 | 2.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.9 | 1.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.9 | 34.9 | GO:0019003 | GDP binding(GO:0019003) |
0.9 | 8.0 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.9 | 3.5 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.9 | 7.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.9 | 2.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.9 | 3.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.9 | 3.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.9 | 14.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.9 | 14.1 | GO:0001848 | complement binding(GO:0001848) |
0.9 | 14.1 | GO:0000049 | tRNA binding(GO:0000049) |
0.9 | 0.9 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.9 | 7.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.9 | 3.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.9 | 3.5 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.9 | 1.7 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.9 | 2.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.9 | 2.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.9 | 12.9 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.9 | 1.7 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.9 | 0.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.9 | 0.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.8 | 11.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.8 | 15.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.8 | 1.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.8 | 5.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.8 | 16.6 | GO:0016748 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.8 | 13.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.8 | 53.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.8 | 9.1 | GO:0000907 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.8 | 1.6 | GO:0034824 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.8 | 4.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 1.6 | GO:0017069 | snRNA binding(GO:0017069) |
0.8 | 6.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.8 | 0.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.8 | 2.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.8 | 20.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.8 | 4.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.8 | 63.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.8 | 4.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.8 | 71.3 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.8 | 2.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.8 | 1.6 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.8 | 3.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.8 | 9.4 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.8 | 1.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.8 | 9.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.8 | 5.5 | GO:0015250 | water channel activity(GO:0015250) |
0.8 | 4.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.8 | 7.0 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.8 | 0.8 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.8 | 3.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.8 | 1.5 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.8 | 3.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.8 | 2.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.8 | 2.3 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.8 | 10.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.8 | 3.0 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.8 | 3.8 | GO:0009055 | electron carrier activity(GO:0009055) |
0.8 | 19.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.8 | 6.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.7 | 14.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.7 | 72.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.7 | 1.5 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.7 | 2.9 | GO:0030515 | snoRNA binding(GO:0030515) |
0.7 | 59.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.7 | 24.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.7 | 5.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.7 | 3.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.7 | 2.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.7 | 8.5 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.7 | 2.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.7 | 61.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.7 | 2.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.7 | 1.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.7 | 2.8 | GO:0038100 | nodal binding(GO:0038100) |
0.7 | 0.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.7 | 19.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.7 | 6.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.7 | 3.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.7 | 4.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.7 | 6.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.7 | 2.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 2.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.7 | 6.1 | GO:0090484 | drug transporter activity(GO:0090484) |
0.7 | 4.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.7 | 21.0 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.7 | 31.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.7 | 0.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.7 | 7.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.7 | 6.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.7 | 2.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.7 | 5.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 0.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.7 | 3.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.7 | 2.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.7 | 3.3 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.7 | 15.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.6 | 3.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.6 | 69.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.6 | 1.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.6 | 11.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.6 | 2.5 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.6 | 1.9 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.6 | 3.7 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.6 | 2.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.6 | 6.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.6 | 7.9 | GO:0019239 | deaminase activity(GO:0019239) |
0.6 | 1.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.6 | 2.4 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) lipase inhibitor activity(GO:0055102) |
0.6 | 11.3 | GO:0051287 | NAD binding(GO:0051287) |
0.6 | 0.6 | GO:0070061 | fructose binding(GO:0070061) |
0.6 | 2.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.6 | 1.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 1.2 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.6 | 3.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 4.1 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.6 | 5.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.6 | 2.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.6 | 2.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.6 | 15.8 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.6 | 3.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 0.6 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.6 | 5.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.6 | 0.6 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.5 | 8.8 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 89.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.5 | 7.0 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.5 | 1.6 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 1.6 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.5 | 1.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.5 | 13.9 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.5 | 3.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 1.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.5 | 8.9 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.5 | 2.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.5 | 3.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.5 | 0.5 | GO:0019956 | chemokine binding(GO:0019956) |
0.5 | 9.5 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.5 | 2.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.5 | 5.3 | GO:0004386 | helicase activity(GO:0004386) |
0.5 | 1.0 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.5 | 2.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 1.4 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.5 | 3.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.5 | 1.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 1.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.5 | 1.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.5 | 37.4 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.5 | 1.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.5 | 1.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 1.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 3.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.4 | 1.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.4 | 1.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 20.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.4 | 2.1 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 13.2 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.4 | 1.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 0.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 75.2 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.4 | 2.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 0.4 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.4 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.4 | 0.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.4 | 1.7 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.4 | 2.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.4 | 0.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.4 | 2.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.4 | 0.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.4 | 7.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.4 | 1.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.4 | 1.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 0.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 7.2 | GO:0016209 | antioxidant activity(GO:0016209) |
0.4 | 0.7 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 1.1 | GO:0015321 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.4 | 2.5 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.4 | 0.4 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.4 | 3.2 | GO:0004518 | nuclease activity(GO:0004518) |
0.4 | 0.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.4 | 0.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 1.8 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.4 | 21.6 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.4 | 2.8 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.4 | 2.5 | GO:0032451 | demethylase activity(GO:0032451) |
0.3 | 2.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 2.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.3 | 1.4 | GO:0005536 | glucose binding(GO:0005536) |
0.3 | 4.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 10.5 | GO:0016853 | isomerase activity(GO:0016853) |
0.3 | 40.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.3 | 1.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 0.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.3 | 12.8 | GO:0008134 | transcription factor binding(GO:0008134) |
0.3 | 3.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 2.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 1.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 1.5 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.3 | 10.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.3 | 0.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 6.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 31.3 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.3 | 2.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 5.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 10.1 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.3 | 1.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 2.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 17.7 | GO:0016887 | ATPase activity(GO:0016887) |
0.3 | 4.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.3 | 2.1 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.2 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 7.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 1.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 0.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 3.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 1.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 0.2 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.2 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 6.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 3.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 8.2 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.2 | 0.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 3.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 0.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 6.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 0.8 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.2 | 0.5 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.2 | 8.5 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 16.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.5 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 3.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.5 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 1.0 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.1 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.1 | 1.0 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 4.1 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.7 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 1.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 1.5 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.1 | 5.8 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.3 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.8 | GO:0016462 | pyrophosphatase activity(GO:0016462) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 38.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
4.8 | 14.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
4.5 | 76.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
4.3 | 42.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
4.2 | 54.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
3.9 | 278.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
3.3 | 179.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
3.3 | 42.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
3.2 | 138.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
3.1 | 132.0 | PID E2F PATHWAY | E2F transcription factor network |
3.1 | 43.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
3.1 | 83.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
3.1 | 95.4 | PID P53 REGULATION PATHWAY | p53 pathway |
3.0 | 18.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
3.0 | 30.0 | PID MYC PATHWAY | C-MYC pathway |
3.0 | 74.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
3.0 | 32.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
3.0 | 47.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
2.9 | 8.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
2.8 | 11.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
2.8 | 5.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
2.8 | 67.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
2.8 | 103.6 | PID PLK1 PATHWAY | PLK1 signaling events |
2.8 | 100.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
2.8 | 27.8 | PID EPO PATHWAY | EPO signaling pathway |
2.7 | 19.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
2.7 | 27.2 | PID ALK2 PATHWAY | ALK2 signaling events |
2.7 | 18.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
2.6 | 26.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
2.6 | 26.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
2.6 | 18.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
2.5 | 22.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
2.4 | 46.2 | ST GAQ PATHWAY | G alpha q Pathway |
2.4 | 90.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
2.4 | 28.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
2.4 | 37.7 | PID AURORA A PATHWAY | Aurora A signaling |
2.4 | 2.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
2.2 | 8.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
2.2 | 28.6 | PID ARF 3PATHWAY | Arf1 pathway |
2.2 | 99.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
2.2 | 49.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
2.1 | 77.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
2.1 | 22.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
2.0 | 10.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
2.0 | 4.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
2.0 | 30.1 | PID BARD1 PATHWAY | BARD1 signaling events |
2.0 | 34.0 | PID ATM PATHWAY | ATM pathway |
2.0 | 25.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
2.0 | 44.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.9 | 11.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.9 | 24.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.9 | 62.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.9 | 5.6 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
1.9 | 78.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
1.9 | 42.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
1.8 | 14.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.8 | 12.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.8 | 3.6 | PID IGF1 PATHWAY | IGF1 pathway |
1.7 | 5.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.7 | 23.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.7 | 45.5 | PID LKB1 PATHWAY | LKB1 signaling events |
1.7 | 16.7 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
1.6 | 11.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
1.6 | 23.0 | PID ATR PATHWAY | ATR signaling pathway |
1.6 | 17.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
1.6 | 14.3 | PID FOXO PATHWAY | FoxO family signaling |
1.6 | 17.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.6 | 31.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.5 | 1.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.5 | 21.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.5 | 19.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.5 | 31.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.4 | 44.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.4 | 24.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.4 | 35.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.4 | 9.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
1.4 | 45.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
1.4 | 2.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.3 | 2.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.3 | 21.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.3 | 22.4 | PID ARF6 PATHWAY | Arf6 signaling events |
1.3 | 21.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.3 | 15.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.3 | 9.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.3 | 12.6 | PID RHOA PATHWAY | RhoA signaling pathway |
1.3 | 12.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.2 | 65.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.2 | 12.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.2 | 8.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.2 | 13.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.2 | 1.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.2 | 3.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.2 | 24.6 | PID BMP PATHWAY | BMP receptor signaling |
1.2 | 11.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.1 | 15.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
1.1 | 2.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.1 | 13.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
1.1 | 22.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.0 | 7.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.0 | 10.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.0 | 12.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.0 | 19.2 | PID AURORA B PATHWAY | Aurora B signaling |
1.0 | 8.9 | PID ALK1 PATHWAY | ALK1 signaling events |
1.0 | 21.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.9 | 2.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.9 | 4.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.9 | 7.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.9 | 18.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.9 | 15.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.8 | 2.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.8 | 4.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.8 | 8.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.8 | 0.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.8 | 2.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.8 | 1.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 5.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.7 | 7.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.7 | 10.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.7 | 9.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.7 | 11.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 7.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.7 | 10.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 5.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.6 | 5.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.6 | 7.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 8.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.5 | 6.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.5 | 3.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.5 | 2.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 2.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.4 | 1.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 7.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.4 | 3.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.4 | 6.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 5.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 1.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 12.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 6.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 1.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 1.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 1.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 2.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 5.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 3.7 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 2.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 1.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 19.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.7 | 9.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
6.9 | 34.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
6.0 | 102.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
5.3 | 74.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
5.3 | 5.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
5.0 | 95.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
4.8 | 4.8 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
4.8 | 19.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
4.6 | 27.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
4.6 | 32.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
4.4 | 34.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
4.3 | 60.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
4.3 | 46.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
4.2 | 33.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
4.2 | 33.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
3.9 | 58.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
3.9 | 35.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
3.9 | 15.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
3.8 | 45.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
3.8 | 22.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
3.6 | 3.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
3.6 | 50.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
3.6 | 36.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
3.4 | 74.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
3.4 | 60.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
3.3 | 59.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
3.2 | 3.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
3.2 | 44.3 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
3.2 | 25.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
3.1 | 56.5 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
3.1 | 3.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
3.0 | 24.1 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
3.0 | 85.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
2.9 | 41.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
2.9 | 105.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
2.8 | 34.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
2.8 | 31.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
2.8 | 28.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
2.8 | 42.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.7 | 2.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
2.7 | 37.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
2.6 | 42.3 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
2.6 | 203.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
2.6 | 59.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
2.5 | 259.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
2.5 | 24.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
2.5 | 31.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.5 | 9.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
2.4 | 9.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
2.4 | 136.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
2.4 | 72.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
2.4 | 31.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
2.4 | 29.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.4 | 4.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
2.4 | 24.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
2.4 | 36.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
2.4 | 21.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
2.4 | 33.4 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
2.4 | 16.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.4 | 26.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
2.3 | 23.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
2.3 | 23.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
2.3 | 36.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
2.3 | 22.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
2.2 | 54.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
2.2 | 54.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
2.2 | 23.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
2.1 | 36.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
2.1 | 72.8 | REACTOME TRANSLATION | Genes involved in Translation |
2.1 | 10.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
2.1 | 14.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
2.1 | 25.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
2.1 | 22.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
2.1 | 174.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
2.0 | 24.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
2.0 | 2.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
2.0 | 18.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.0 | 17.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.0 | 64.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
1.9 | 64.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
1.9 | 30.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.8 | 31.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.8 | 9.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
1.8 | 40.6 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
1.8 | 78.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.8 | 72.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.8 | 10.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.8 | 12.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.8 | 8.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.7 | 29.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.7 | 31.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
1.7 | 38.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.7 | 302.6 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
1.7 | 18.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
1.7 | 18.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.7 | 8.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.7 | 43.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.7 | 3.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.6 | 6.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
1.6 | 1.6 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
1.6 | 26.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.6 | 1.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.6 | 26.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.6 | 6.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
1.6 | 14.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.6 | 6.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
1.6 | 14.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
1.6 | 22.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
1.6 | 9.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.6 | 15.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
1.5 | 1.5 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
1.5 | 23.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
1.5 | 19.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.5 | 25.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.5 | 16.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.5 | 13.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.5 | 14.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.5 | 8.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.5 | 16.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.5 | 14.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
1.4 | 40.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.4 | 25.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.4 | 18.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.4 | 19.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.4 | 14.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.4 | 16.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.4 | 4.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.4 | 20.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.4 | 58.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.3 | 6.7 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
1.3 | 9.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.3 | 26.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.3 | 82.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
1.3 | 39.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.3 | 5.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.3 | 1.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.3 | 7.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.3 | 24.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.3 | 23.9 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.2 | 9.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.2 | 50.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
1.2 | 9.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.2 | 2.4 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
1.2 | 11.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.2 | 9.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
1.2 | 15.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.2 | 5.8 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
1.1 | 34.2 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
1.1 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.1 | 7.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.1 | 18.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
1.1 | 22.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.1 | 7.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.1 | 6.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
1.1 | 13.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.1 | 2.2 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
1.1 | 7.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.1 | 30.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.1 | 7.5 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
1.1 | 58.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.0 | 5.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.0 | 12.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.0 | 21.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.0 | 40.9 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
1.0 | 8.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.0 | 11.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.9 | 1.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.9 | 5.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 5.6 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.9 | 0.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.9 | 3.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.9 | 0.9 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.9 | 9.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.9 | 13.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.8 | 14.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.8 | 15.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.8 | 10.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.8 | 12.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.8 | 1.6 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.8 | 9.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.8 | 3.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.7 | 4.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.7 | 0.7 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.7 | 0.7 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.7 | 18.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.7 | 1.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.7 | 2.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.7 | 0.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.7 | 4.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.7 | 0.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.6 | 22.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.6 | 11.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.6 | 12.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.6 | 3.6 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.6 | 17.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.6 | 13.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.6 | 5.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.6 | 8.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.6 | 14.1 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.5 | 5.4 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.5 | 1.6 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.5 | 5.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.5 | 7.4 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.5 | 8.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.5 | 4.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.5 | 0.5 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.5 | 11.6 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.4 | 18.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 3.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 1.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.4 | 19.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 1.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.4 | 24.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 6.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.4 | 2.5 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.3 | 0.3 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.3 | 1.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 3.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.3 | 2.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 0.6 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.3 | 2.2 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.2 | 3.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 1.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 0.5 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 4.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 0.7 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.2 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 5.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 1.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 3.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 7.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 1.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 0.4 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 3.4 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 3.8 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.1 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.3 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 2.2 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 1.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |